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Abstract 
Obesity is a major risk factor for the development of hypertension and it is 
associated with hyperglycemia, hyperinsulinemia (type II diabetes), sodium 
retention and oxidative stress. However, the mechanisms involved in obesity 
related development of hypertension are not clearly understood. Development of 
hypertension can be explained in part by sodium retention resulting from 
impaired regulation of sodium homeostasis. Renal dopamine, acting via the renal 
dopamine D1 receptor (D1R), promotes the excretion of sodium and plays a vital 
role in the maintenance of sodium homeostasis.  
Impairment of D1R function is associated with hypertension in humans and 
animal models including Leprfa/fa Zucker (obese) rats. We have previously 
reported that treatment of these rats with antioxidants or insulin sensitizers 
reduced insulin levels and oxidative stress, restored D1R function and reduced 
blood pressure. Further, the redox sensitive transcription factor, nuclear factor κ 
B (NFκB) has been implicated in impairment of D1R function during oxidative 
stress.  
We investigated the effect of exercise on insulin levels, oxidative stress, nuclear 
translocation of NFκB, blood pressure, albuminuria, and D1R function. The 
exercise protocol involved treadmill exercise from three weeks of age for eight 
weeks. Exercise reduced oxidative stress, nuclear translocation of NFκB and 
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albuminuria. However, exercise did not reduce plasma insulin levels or blood 
pressure. Also, selective D1R agonist (SKF38393) mediated increases in GTPγS 
binding and sodium excretion were impaired in obese rats compared to lean rats 
and exercise did not restore this defect. We concluded that, although exercise is 
beneficial in reducing oxidative stress and renal injury, reducing insulin levels 
may be required to restore D1R function in obese rats. This hypothesis is 
supported by our findings that three-week-old Leprfa/fa Zucker (obese) rats do not 
display oxidative stress, increased nuclear translocation of NFκB, or elevated 
blood pressure. However, they display hyperinsulinemia and impaired inhibition 
of Na+/K+ ATPase in response to D1R agonist. 
Caloric restriction has been shown to attenuate hyperinsulinemia in obese rats. 
We hypothesized that caloric restriction in obese rats, starting from an early age, 
will reduce insulin levels, restore D1R function, and reduce blood pressure. 
Caloric restriction in obese rats reduced insulin levels by ~50%. However, it did 
not reduce oxidative stress, did not restore D1R function, or reduce blood 
pressure. 
Therefore, we conclude that both hyperinsulinemia and oxidative stress can 
independently impair renal dopamine D1 receptor function and contribute to the 
development of hypertension in obese rats. Simultaneously reducing both 
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oxidative stress and hyperinsulinemia might be required to restore renal 
dopamine D1 receptor function and lower blood pressure. 
 vii 
TABLE OF CONTENTS 
List of Abbreviations List of Figures 
1. INTRODUCTION AND STATEMENT OF THE PROBLEM 
2. REVIEW OF LITERATURE 
2.1 Role of kidney in sodium homeostasis 
2.2 Role of dopamine in regulation of sodium excretion 
2.3 Dopamine receptors and signal transduction   2.3.1 Classification of dopamine receptors 2.3.2 Renal dopamine D1‐like receptors   2.3.2.1 Distribution in the kidney 
  2.3.2.2 Signal transduction in proximal tubules 
2.4 Renal dopamine D1 receptor impairment in pathogenesis of 
hypertension 
2.5 Impaired sodium homeostasis and renal dopamine D1 receptor 
function in obesity associated hypertension   2.5.1 Role of hyperinsulinemia and hyperglycemia 2.5.2 Role of oxidative stress and redox sensitive transcription factor nuclear factor κ B (NFκB) 
2.6 Role of exercise 
xiv  xviii  1  6  6  7  8  8  9  9  10   11    12   12   15   19  
 viii 
2.7 Role of calorie restriction 
3. MATERIALS AND METHODS 
3.1 Studies at three weeks of age 
  3.1.1 Protocol for studies at three weeks of age 3.1.2 Surgical procedure for measurement of blood pressure and tissue collection 3.1.3 Measurement of blood glucose and lipid profile 3.1.4 Measurement of fasting plasma insulin and insulin sensitivity 3.1.5 Preparation of renal proximal tubules   3.1.5.1 Preparation of renal cortical tubular suspension 
  3.1.5.2 Enrichment of renal proximal tubules 3.1.6 Test for renal proximal tubular viability 3.1.7 Measurement of Na+/K+ ATPase activity 3.1.8 Preparation of renal proximal tubular membranes 3.1.9 [3H]SCH23390 binding for renal dopamine D1 receptor 3.1.10 [35S]GTPγS binding 3.1.11 Immunoblotting for G proteins 3.1.12 Oxidative stress markers   3.1.12.1 Measurement of protein carbonylation 
  3.1.12.2 Measurement of plasma and urinary 8­Isoprostane 
20  24  24  24   25   26  26  27  27  28  29  30  31  31  32  33  34  34  35  
 ix 
  3.1.12.3 Measurement of protein nitrosylation 
  3.1.12.4 Measurement of whole blood glutathione levels 
  3.1.12.5 Measurement of hemeoxygenase­1 (HO­1) levels 
  3.1.12.6 Measurement of superoxide dismutase (SOD) activity 3.1.13 Measurement of nuclear translocation of nuclear factor κ B (NFκB)   3.1.13.1 Separation of nuclear and cytosolic fractions 
  3.1.13.2 Immunoblotting for NFκB 
3.2 Protocol for exercise study 
  3.2.1 Animals and exercise protocol 3.2.2 Surgical procedure for measurement of blood pressure and tissue collection 3.2.3 Measurement of blood glucose and lipid profile 3.2.4 Measurement of fasting plasma insulin and insulin sensitivity 3.2.5 Oxidative stress markers   3.2.5.1 Measurement of urinary 8­Isoprostane 
  3.2.5.2 Measurement of malondialdehyde (MDA) levels 
  3.2.5.3 Measurement of whole blood glutathione levels 
  3.2.5.4 Measurement of superoxide dismutase (SOD) activity 3.2.6 Measurement of urinary albumin excretion 
36  36  37  38   39   39  40  41  41   42   42  42  42  42  43  43  43  44  
 x 
3.2.7 Measurement of natriuretic response to selective D1R agonist  3.2.8 Measurement of creatinine levels 3.2.9 Preparation of proximal tubules 3.2.10 Test for renal proximal tubular viability 3.2.11 Preparation of proximal tubular membranes 3.2.12 [35S]GTPγS binding 3.2.13 Measurement of nuclear translocation of nuclear factor κ B (NFκB) 
3.3 Protocol for caloric restriction study   3.3.1 Animals and caloric restriction protocol 3.3.2 Surgical procedure for measurement of blood pressure and tissue collection 3.3.3 Measurement of blood glucose and lipid profile 3.3.4 Measurement of fasting plasma insulin and insulin sensitivity 3.3.5 Oxidative stress markers   3.3.5.1 Measurement of protein carbonylation 
  3.3.5.2 Measurement of plasma and urinary 8­Isoprostane 
  3.3.5.3 Measurement of protein nitrosylation 
  3.3.5.4 Measurement of superoxide dismutase (SOD) activity 
  3.3.5.5 Measurement of malondialdehyde (MDA) levels 
45  47  47  47  47  48   48   48  48   49   49  49  50  50  50  50  50  50  
 xi 
3.3.6 Measurement of natriuretic response to selective D1R agonist 
4. RESULTS 
4.1 Studies at three weeks of age 4.1.1 General physiological parameters   4.1.2 Levels of oxidative stress markers     4.1.2.1 Proximal tubular protein carbonylation 
    4.1.2.2 Plasma and urinary 8­isoprostane 
    4.1.2.3 Proximal tubular protein nitrosylation 
    4.1.2.4 Whole blood glutathione levels 
    4.1.2.5 Plasma and renal proximal tubular hemeoxygenase­1 
levels 
4.1.2.6 Plasma and renal proximal tubular superoxide dismutase 
(SOD) activity 4.1.3 Inhibition of renal proximal tubular Na+/K+ ATPase activity by D1R agonist 4.1.4 Renal proximal tubular dopamine D1 receptor‐G protein coupling 4.1.5 Renal proximal tubular membrane Dopamine D1 receptor levels 
4.1.6 Nuclear translocation of NFκB in renal proximal tubules 
4.2 Effect of exercise 
51  53  53  53  54  54  54  54  55   55    55    55   56  56   57  57   
 xii 
4.2.1 Effect of exercise on general physiological parameters 
4.2.2 Effect of exercise on oxidative stress 
  4.2.2.1 Urinary 8­Isoprostane 
  4.2.2.2 Renal malondialdehyde (MDA) 
  4.2.2.3 Whole blood glutathione 
  4.2.2.4 Plasma and proximal tubular superoxide dismutase (SOD) 
4.2.3 Effect of exercise on urinary albumin excretion 
4.2.4 Effect of exercise on natriuretic response to D1R agonist 
4.2.5 Effect of exercise on D1R agonist induced dopamine D1 receptor‐G protein coupling 
4.2.6 Effect of exercise on nuclear translocation of nuclear factor κ B (NFκB) 
4.3 Effect of caloric restriction 
  4.3.1 Effect of caloric restriction on general physiological parameters 
  4.3.2 Effect of caloric restriction on oxidative stress 
57  59   59   59  59   59   60   60    61    61    61  62  63  
 xiii 
    4.3.2.1 Plasma and urinary 8­isoprostane 
    4.3.2.2 Renal cortical protein carbonylation 
    4.3.2.3 Renal cortical nitrosylation 
    4.3.2.4 Plasma and renal cortical superoxide dismutase 
    4.3.2.5 Renal cortical malondialdehyde 
  4.3.3 Effect of caloric restriction on natriuretic response to D1R agonist   
5. DISCUSSION 
6. SUMMARY AND CONCLUSIONS 
6.1 Summary 
6.2 Conclusions 
7. REFERENCES 
63 
63  63  64   64  64   105  117  117  118  119 
 
 
 
 
 xiv 
LIST OF ABBREVIATIONS 
AC 
AChE 
ANP 
BHT 
BMI 
BSA 
BSO 
CER 
CLcreatinine 
COX 
D1R 
DAG 
DBP 
DNP-hydrazone 
DNPH 
DTNB 
Adenylyl cyclase 
Acetylcholine Esterase 
Atrial natriuretic peptide 
Butylated hydroxy-toluene 
Body mass index 
Bovine serum albumin 
Buthionine sulfoxime 
Cytoplasmic extraction reagent 
Creatinine clearance 
Cyclo-oxygenase 
Dopamine D1 receptor 
Diacylglycerol 
Diastolic blood pressure 
2,4-dinitrophenylhydrazone 
2,4-dinitrophenylhydrazine 
5,5’-Dithiobis-2-nitrobenzoic acid 
 xv 
DS 
EDTA 
EIA 
ELISA 
FENa 
GFR 
GPCR 
GRK 
GSH 
GSSG 
GTPγS 
H2O2 
HO-1 
IP3 
KHB 
L-DOPA 
MDA 
Dahl salt sensitive rats 
Ethylene-diamine-tetra-acetic acid 
Enzyme immunosorbent assay 
Enzyme linked immunosorbent assay 
Fractional excretion of sodium 
Glomerular filtration rate 
G protein coupled receptors 
G protein-coupled receptor kinase 
Reduced glutathione 
Oxidized glutathione 
Guanosine 5'-O-[gamma-thio]triphosphate 
Hydrogen peroxide 
Hemeoxygenase-1 
Inositol-tris-phosphate 
Krebs–Henseleit buffer 
L-3,4-dihydroxyphenylalanine 
Malondialdehyde  
 xvi 
MAP 
NADPH 
NaPi2 
NER 
NHE3 
NFκB 
PAGE 
PBST 
PEG 
PKA 
PKC 
PLA2 
PLC 
PMSF 
PVDF 
QUICKI 
RIA 
Mean arterial pressure 
Nicotinamide adenine dinucleotide phosphate 
Na+/phosphate co-transporter type 2 
Nuclear extraction reagent 
Na+/H+ exchanger type 3 
Nuclear factor κ B 
Polyacrylamide gel electrophoresis 
Phosphate buffered saline-tween 
Polyethylene glycol 
Protein kinase A 
Protein kinase C 
Phospholipase A2 
Phospholipase C 
Phenyl methyl sulfonyl fluoride 
Polyvinylidene fluoride 
Quantitative insulin sensitivity check index 
Radio-immuno assay 
 xvii 
ROS 
SBP 
SHR 
SD 
SDS 
SOD 
TBARS 
TBS 
TBS-T 
TEMPOL 
UNaV 
Reactive oxygen species 
Systolic blood pressure 
Spontaneously hypertensive rats 
Sprague Dawley rats 
Sodium dodecyl sulfate 
Superoxide dismutase 
Thiobarbituric acid reactive substances 
Tris-buffered-saline 
Tris-buffered-saline with tween-20 
4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl 
Urinary sodium excretion 
 
 
 
 
 
 
 xviii 
LIST OF FIGURES 
Figure 1 (A) Mean arterial pressure (MAP), (B) fasting blood glucose (C) fasting 
plasma insulin, and (D) quantitative insulin check index (QUICKI) in three week 
old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats. 
Figure 2 Protein carbonylation in renal proximal tubular homogenate from three 
week old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats. 
Figure 3 (A) Plasma 8-isoprostane and (B) Urinary 8-isoprostane in three week 
old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats. 
Figure 4 Protein nitrosylation in renal proximal tubular homogenate from three 
week old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats. 
Figure 5 (A) Whole blood reduced glutathione (GSH) and oxidized glutathione 
(GSSG) levels and (B) Ratio of GSH to GSSG in three week old Lepr+/+ Zucker 
(lean) and Leprfa/fa Zucker (obese) rats. 
Figure 6 Hemeoxygenase-1 (HO-1) levels in (A) Plasma and (B) renal proximal 
tubular homogenate from three week old Lepr+/+ Zucker (lean) and Leprfa/fa 
Zucker (obese) rats. 
 xix 
Figure 7 Superoxide dismutase (SOD) activity in (A) Plasma and (B) renal 
proximal tubular homogenate from three week old Lepr+/+ Zucker (lean) and 
Leprfa/fa Zucker (obese) rats. 
Figure 8 (A) SKF38393 mediated inhibition of Na+/K+ ATPase activity, expressed 
as percentage of basal Na+/K+ ATPase activity (B) Basal Na+/K+ ATPase activity, 
in proximal tubular preparation from three week old Lepr+/+ Zucker (lean) and 
Leprfa/fa Zucker (obese) rats. 
Figure 9 (A) SKF38393 mediated stimulation of [35S]GTPγS binding, expressed 
as percentage over basal [35S]GTPγS binding (B) Basal [35S]GTPγS binding, in 
proximal tubular membranes from three week old Lepr+/+ Zucker (lean) and 
Leprfa/fa Zucker (obese) rats. 
Figure 10 (A) Gsα and (B) Gq/11α levels, in proximal tubular homogenates from 
three week old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats. 
Figure 11 Dopamine D1 receptor radioligand ([3H]SCH23390) binding in 
proximal tubular membranes from three week old Lepr+/+ Zucker (lean) and 
Leprfa/fa Zucker (obese) rats. 
Figure 12 Nuclear factor κ B (NFκB) levels in renal proximal tubular nuclear and 
cytosolic fractions from three week old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker 
(obese) rats. 
 xx 
Figure 13 Effect of exercise on (A) food intake (B) water intake (C) body weight. 
Figure 14 Effect of exercise on (A) mean arterial pressure (MAP) (B) fasting 
blood glucose (C) fasting plasma insulin, and (D) quantitative insulin check index 
(QUICKI). 
Figure 15 Effect of exercise on urinary 8-isoprostane. 
Figure 16 Effect of exercise on proximal tubular malondialdehyde (MDA). 
Figure 17 Effect of exercise on blood total glutathione levels. 
Figure 18 Effect of exercise on (A) plasma superoxide dismutase (SOD) activity 
(B) proximal tubular homogenate SOD activity. 
Figure 19 Effect of exercise on urinary albumin levels. 
Figure 20 Effect of exercise on urine flow. 
Figure 21 Effect of exercise on urinary sodium excretion (UNaV). 
Figure 22 Effect of exercise on fractional excretion of sodium (FENa). 
Figure 23 Effect of exercise on glomerular filtration rate (GFR). 
Figure 24 Effect of exercise on (A) Stimulation of membrane [35S]GTPγS binding 
in response to SKF38393, expressed as percentage over basal [35S]GTPγS 
binding (B) basal [35S]GTPγS binding. 
 xxi 
Figure 25 Effect of exercise on nuclear translocation of NFκB. 
Figure 26 Effect of caloric restriction on (A) food intake (B) water intake (C) body 
weight. 
Figure 27 Effect of caloric restriction on (A) mean arterial pressure (MAP) (B) 
fasting blood glucose (C) fasting plasma insulin, and (D) quantitative insulin 
check index (QUICKI). 
Figure 28 Effect of caloric restriction on (A) plasma 8-isoprostane (B) urinary 8-
isoprostane. 
Figure 29 Effect of caloric restriction on renal cortical protein carbonylation. 
Figure 30 Effect of caloric restriction on renal cortical protein nitrosylation. 
Figure 31 Effect of caloric restriction on (A) plasma superoxide dismutase (SOD) 
activity (B) renal cortical homogenate SOD activity. 
Figure 32 Effect of caloric restriction on renal cortical homogenate 
malondialdehyde (MDA) levels. 
Figure 33 Effect of caloric restriction on urine flow. 
Figure 34 Effect of caloric restriction on urinary sodium excretion (UNaV). 
 
Page 1 of 152 
1. Introduction and statement of the problem: 
Obesity is a major risk factor for the development of hypertension and it is 
associated with hyperglycemia, hyperinsulinemia (type II diabetes), sodium 
retention and oxidative stress (12, 47, 109, 140, 158, 185, 188, 190). However, 
the mechanisms involved in obesity related development of hypertension and 
accompanying complications are not clearly understood (60, 190, 191). 
Development of hypertension can be explained in part by impaired regulation of 
sodium homeostasis (37, 60, 103, 190). Numerous studies, both in animal 
models and humans, point towards an involvement of defective renal dopamine 
D1 receptor function in impairment of sodium homeostasis and pathogenesis of 
hypertension (121). In animal models, dopamine mediated natriuresis is 
diminished in obese Zucker rats (111, 137, 143), spontaneously hypertensive 
rats (SHR) (50, 72) and Dahl salt-sensitive rats (DS) (100). This phenomenon is 
associated with decreased ability of dopamine to inhibit both Na+/H+ exchanger 
and Na+/K+ ATPase (110, 111, 137). 
An increasing number of studies, in several models of hypertension as well as in 
old Fischer344 rats (64) and Sprague Dawley (SD) rats treated with pro-oxidants 
(30), indicate a critical role of oxidative stress in the impairment of dopamine D1 
receptor function. In these models, natriuresis and inhibition of Na+/K+ ATPase in 
response to dopamine D1 receptor agonists is reduced (30, 64). This has been 
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attributed to dopamine D1 receptor uncoupling from G proteins and receptor 
downregulation (30, 64). Studies in both animal models and cell cultures have 
shown the involvement of nuclear factor κ B (NFκB), a redox sensitive 
transcription factor, in D1 receptor-G protein uncoupling (27, 63). Also, in these 
studies, antioxidant treatment prevented the nuclear translocation of NFκB 
leading to restoration of D1 receptor-G protein coupling, D1 receptor mediated 
inhibition of Na+/K+ ATPase and D1 receptor mediated natriuresis (27, 63, 64). 
Adult obese Zucker rats that are used as a genetic model to study obesity-
associated hypertension exhibit hyperglycemia, hyperinsulinemia and oxidative 
stress (4). Treatment of adult obese Zucker rats with both insulin sensitizers 
(rosiglitazone) and the antioxidant tempol (4-Hydroxy-2,2,6,6-
tetramethylpiperidine-N-oxyl) decreased oxidative stress, improved insulin 
sensitivity, restored dopamine D1 receptor mediated natriuresis and reduced 
blood pressure (21, 32, 208-210). 
Like antioxidants, exercise reduces oxidative stress in part by augmenting 
physiological anti-oxidant mechanisms (48, 126). Asghar et al (19) have shown 
that exercise augments antioxidant defenses, reduces oxidative stress and 
restores renal dopamine D1 receptor function in old Fischer344 rats. However, it 
is not known if exercise can reduce oxidative stress, prevent impairment of 
dopamine D1 receptor function and development of hypertension in obese 
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Zucker rats. Therefore, we wanted to investigate the influence of exercise on 
oxidative stress, insulin sensitivity, D1 receptor function and development of 
hypertension in obese Zucker rats.  
Furthermore, reports indicate that overweight adolescents are about twenty times 
more likely than their leaner peers to be obese in adulthood (130). Therefore, 
preventing or reducing obesity early on in life may be more cost effective 
considering the enormous costs associated with management of comorbidities 
associated with obesity related hypertension (130). It is suggested that there are 
sensitive or critical periods during early life and interventions during this phase 
may be more likely to alter lifelong physiological processes than in adulthood 
(130). Leprfa/fa (obese) Zucker rats at three weeks of age are of similar weight as 
their lean counterparts. Since obese Zucker rats express the obese phenotype 
only by 6-7 weeks of age, we hypothesized that exercising obese Zucker rats 
from three-four weeks of age will improve insulin sensitivity and prevent oxidative 
stress. These changes will prevent nuclear translocation of NFκB, impairment of 
D1 receptor mediated natriuresis and increase in blood pressure in adult obese 
Zucker rats. 
Caloric restriction is another lifestyle intervention that is recommended for 
treatment of obesity related comorbidities (78, 130). Caloric restriction to reduce 
weight in hypertensive patients is associated with improvement of insulin 
Page 4 of 152 
sensitivity and a reduction of blood pressure (155, 160). Recently, Metcalf et al 
(148) suggested that physical inactivity is a result rather than a cause for obesity 
and that interventions aimed at reducing weight should focus on reducing caloric 
intake. More importantly, in obese Zucker rats, hyperphagia is a major contributor 
to the acceleration of weight gain (16, 201). Caloric restriction in these rats is 
associated with decrease in weight gain (201, 225) and decrease in 
hyperinsulinemia (22, 141). Caloric restriction, in both humans and animal 
models, is associated with a decrease in oxidative stress (39, 120, 123, 200, 211, 
224). However, in the presence of disease states, caloric restriction may not 
reduce oxidative stress as effectively or even be detrimental (173, 200). 
Literature addressing the ability of caloric restriction to reduce blood pressure in 
obese Zucker rats is limited and offers conflicting results (131, 141). It is not 
known if caloric restriction can prevent the impairment of dopamine D1 receptor 
function in obese Zucker rats. 
Starting caloric restriction at an early age may offer greater benefit (130, 141). 
However, because of concerns that restricting calories at 3-4 weeks of age may 
interfere with development, we decided to restrict calories starting at 6-7 weeks 
of age. In addition, based on the data from exercise study and three-week-old 
Leprfa/fa (obese) Zucker rats, we hypothesized that restricting caloric intake in 
obese Zucker rats from 6-7 weeks of age for ten weeks will decrease insulin 
Page 5 of 152 
levels, restore dopamine D1 receptor mediated natriuresis, and reduce blood 
pressure. 
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2. REVIEW OF LITERATURE: 
2.1 Role of Kidney in Sodium Homeostasis: 
Kidney plays a vital role in the maintenance of sodium homeostasis, extracellular 
fluid volume and blood pressure (90, 91, 146, 222). The kidney is composed of 
functional units called the nephron. The kidney regulates sodium homeostasis 
and extracellular fluid volume by means of filtration and subsequent reabsorption 
through a variety of sodium and water transporters found along the entire length 
of the nephron. The type of transporters, their relative abundance and extent of 
sodium and fluid reabsorption vary across the various segments of the nephron 
(147). The proximal tubular segment is responsible for reabsorption of ~70% of 
the glomerular filtrate (both sodium and water) (147). Sodium is absorbed 
passively at the apical surface of proximal tubular epithelium that expresses 
various sodium transporters like Na+/H+ exchanger type 3 (NHE3), Na+/glucose 
co-transporter, Na+/amino acid co-transporter and the Na+/phosphate co-
transporter type 2 (NaPi2) (147, 184). The loop of Henle at the luminal side, 
passively reabsorbs approximately another 20% of the sodium primarily via the 
Na+/K+/2Cl- co-transporter (54, 87, 92, 184). In the distal tubule, sodium is 
reabsorbed passively at the luminal side primarily via the Na+/Cl- carrier (184). In 
the collecting tubules and collecting ducts, sodium is reabsorbed at the luminal 
side via NHE3 and sodium channels by a passive process (184). The 
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electrochemical gradient needed to maintain the above passive processes is 
primarily generated by the basolateral Na+/K+ ATPase (147, 184). Na+/K+ 
ATPase actively transports the sodium entering from the apical side, out of the 
epithelia and into circulation (184). Water reabsorption in all the segments, 
except the collecting tubules and ducts, occurs by paracellular diffusion and is 
coupled to electrolyte reabsorption (184). In the collecting tubules and ducts, 
presence of zona occludens (tight junctions) prevents paracellular diffusion (184). 
Here, water is passively reabsorbed transcellularly via aquaporins and is 
dissociated from electrolyte reabsorption (184).  
The kidney is under the control of neuronal and hormonal factors (45, 146, 147, 
223). Several hormones tightly regulate the various transporters and hence the 
extent of sodium and fluid reabsorption (15, 54, 92, 170, 216). Under normal 
conditions, anti-natriuretic hormonal factors like angiotensin II and 
norepinephrine predominate and promote reabsorption and maintain sodium 
homeostasis. However, under conditions of increased sodium intake anti-
natriuretic hormones like dopamine and atrial natriuretic peptide (ANP) 
predominate and promote excretion of sodium (13). 
2.2 Role of Dopamine in Regulation of Sodium Excretion: 
Within the kidney, dopamine is synthesized locally in the proximal tubules. 
Levodopa (L-DOPA) in the glomerular filtrate is taken up by the nephron 
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epithelium and decarboxylated to dopamine by the aromatic amino acid 
decarboxylase. Majority of this conversion takes place in proximal tubular 
segment of the nephron (24, 93, 94, 102). Dopamine has both natriuretic and 
diuretic effects. Dopamine mediated inhibition of proximal tubular sodium 
reabsorption is a major contributor for the natriuretic effect of endogenously 
synthesized dopamine (35, 121, 135, 136). The natriuretic effect of dopamine is 
more prominent in euvolemic and volume expanded states and during sodium 
loading. In fact, dopamine during moderate sodium loading (5% of body weight) 
is responsible for approximately 50% of the increase in sodium excretion (105). 
Although a majority of renal dopamine is synthesized in the proximal tubules, it 
can act at multiple sites along the nephron. It promotes natriuresis by inhibiting 
sodium transport by an autocrine effect on proximal tubules and a paracrine 
effect at other segments like the medullary thick ascending limb and cortical 
collecting ducts (71, 199). However, its proximal tubular effects have drawn 
greater attention because most of the filtered sodium load (~70%) is reabsorbed 
in proximal tubules (147). 
2.3 Dopamine receptors and signal transduction: 
2.3.1 Classification of dopamine receptors: 
Dopamine acts via the rhodopsin-like family of G protein coupled receptors 
(GPCR). Dopamine receptors are classified into two types, D1-like and D2-like 
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receptors (124). The D1-like receptors are further classified into two subtypes, 
D1 and the D5 receptors (named D1A and D1B respectively, in rodents). Both D1 
and D5 subtypes are positively coupled to adenylyl cyclase (AC) via Gsα and the 
D1 subtype is additionally also coupled to phospholipase C via Gq/11α. The D2-
like receptors are further classified into D2, D3 and D5 subtypes (115). All the D2 
like receptors are coupled negatively to AC via Gi (121). Both dopamine D1-like 
and D2-like receptors are expressed in the kidney. Renal dopamine receptors, 
like other peripheral dopamine receptors, display lower affinity (Kd) than striatal 
(brain) dopamine receptors (6, 7, 11). The inhibitory effect of dopamine on 
sodium reabsorption is primarily mediated via the D1-like receptors (135). 
2.3.2 Renal dopamine D1-like receptors: 
2.3.2.1 Distribution in the kidney:  
Renal D1-like receptors are expressed to a greater extent in the renal 
cortex than in the medulla (135). D1-like receptors are located in all 
nephron segments including proximal convoluted tubule, pars recta, loop 
of Henle, distal convoluted tubule, juxtaglomerular cells, cortical and 
medullary collecting tubules (204). The proximal tubular segment displays 
the highest density of D1-like receptors compared to other tubular 
segments as well as the renal cortical vasculature (6-11, 204). However, 
glomeruli do not express any D1-like receptors (10). In the proximal 
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tubules, D1-like receptors are expressed on both the luminal and 
basolateral membranes (70). 
2.3.2.2 Signal transduction in proximal tubules: 
The inhibitory effect of dopamine on sodium transport at both the luminal 
and basolateral side is mediated by the D1-like receptors (135). At the 
luminal side, activation of D1-like receptors coupled to Gsα leads to 
activation of adenylyl cyclase and increased cAMP levels and subsequent 
activation of cAMP dependent protein kinase (PKA) (34, 65, 68). PKA 
mediated phosphorylation of NHE3 results in inhibition of NHE3 activity 
(34, 108). In addition, a cAMP independent and G-protein dependent 
mechanism for inhibition of luminal NHE3 has been proposed (66). 
At the basolateral side, activation of D1-like receptors coupled to 
Gq/11α leads to activation of phospholipase C (PLC) and generation of 
inositol tris phosphate (IP3) and diacylglycerol (DAG) (67, 69). DAG 
mediated activation of protein kinase C (PKC) leads to phosphorylation 
and inhibition of the basolateral Na+/K+ ATPase (36, 135). It is possible 
that dopamine inhibits basolateral Na+/K+ ATPase indirectly via 20-
hydroxyeicosatetraenoic acid (20-HETE) (167, 195, 196). This indirect 
pathway involves PLC/PKC mediated activation of phospholipase A2 
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(PLA2) and generation of arachidonic acid that is converted to 20-
hydroxyeicosatetraenoic acid (20-HETE) by cytochrome P450 (113, 167).  
The above inhibitory actions of dopamine on luminal NHE3 and 
basolateral Na+/K+ ATPase decrease proximal tubular sodium 
reabsorption and hence increase urinary sodium excretion (13, 14, 135, 
138). 
2.4 Renal dopamine D1 receptor impairment in pathogenesis of 
hypertension: 
Numerous studies, in both hypertensive animal models and humans, point 
towards an involvement of a defective renal dopamine D1-like receptor function 
in the pathogenesis of hypertension (121, 193). Dopamine mediated natriuresis 
is impaired in obese Zucker rats (143), spontaneously hypertensive rats (SHR) 
(50, 72, 112), Dahl salt-sensitive rats (DS) (56, 100, 151, 165) and old 
Fischer344 rats (215). The impaired dopamine receptor mediated natriuresis is 
associated with decreased ability of dopamine to inhibit both NHE3 and Na+/K+ 
ATPase (20, 110-112, 137, 165). This decreased ability to inhibit NHE3 and 
Na+/K+ ATPase may involve uncoupling of G proteins from D1-like receptors (28, 
33, 110, 111, 114, 122, 137, 168) and/or downregulation of D1-like receptors (33, 
111, 122, 210). It is also reported that disruption of D1A receptor gene in mice 
causes elevations in blood pressure (3). 
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2.5 Impaired sodium homeostasis and renal dopamine D1 receptor function 
in obesity associated hypertension:  
2.5.1 Role of hyperinsulinemia and hyperglycemia: 
A number of studies report an association between obesity and impaired sodium 
excretion leading to development of hypertension (96, 192). In addition, 
numerous studies report an association between insulin resistance, 
hyperinsulinemia, hyperglycemia and impaired sodium excretion that ultimately 
contributes to development of hypertension (57, 73-77, 127, 132, 139, 157, 189-
191). However, the role of hyperinsulinemia as a primary mediator in impairment 
of sodium excretion and development of hypertension is unresolved (95, 97). 
High fat diet causes obesity, insulin resistance, sodium retention and blood 
pressure elevations in dogs. In contrast, hyperinsulinemia induced in dogs by 
insulin infusion did not cause sodium retention or elevate blood pressure (95, 98, 
99). The apparent difference between these two studies might be due to insulin 
resistance or some other factor that is present in obese dogs but not in normal 
dogs (97). However, hyperinsulinemia induced by insulin infusion increases 
blood pressure in Sprague Dawley rats (2, 41, 43). In these rats, Brands et al 
(40, 41, 43) report that there is no sodium retention associated with the increase 
in blood pressure using insulin infusion (1-1.5 mU/kg/min) for upto one week. In 
contrast, Banday and Lokhandwala (2) report that insulin infusion (5-7 
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mU/kg/min) in these rats for three weeks impairs sodium excretion and inhibition 
of proximal tubular Na+/K+ ATPase in response to dopamine D1 receptor 
agonists. The differences between the studies in dogs and rats can be attributed 
to species differences. Further, the differences between studies in rats can be 
attributed to the duration and magnitude of dosing. Most importantly, the fact that 
Brands et al (40, 41, 43) did not notice an increase in sodium excretion, despite 
the increase in blood pressure, might indicate increased sodium reabsorption 
(97). The increasing blood pressure and accompanying pressure natriuresis 
compensate for the increased sodium reabsorption and achieve equilibrium to 
maintain sodium balance (97). This compensation by pressure natriuresis may 
diminish with chronic exposure to hyperinsulinemia and/or other factors and 
contribute to further elevation of blood pressure (97). Therefore, insulin mediated 
increase in tubular sodium reabsorption might play a pivotal role in the 
development of obesity-associated hypertension (2, 89, 97). 
Increased renal tubular reabsorption of sodium is observed in Leprfa/fa (obese) 
Zucker rats that are used as a model to study obesity, diabetes and hypertension 
(4, 16). Homozygous Leprfa/fa Zucker rats become overtly obese by 5-6 weeks of 
age (4, 16). Our lab has shown that dopamine D1 receptor mediated natriuresis 
and inhibition of both NHE3 and Na+/K+ ATPase is impaired in adult obese 
Zucker rats (110, 111, 137, 143). Furthermore, this defect may be due to 
downregulation of dopamine D1 receptors and their reduced coupling to G 
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proteins (111, 137). Since hyperinsulinemia (3-5 weeks of age) and 
hyperglycemia (6-8 weeks of age) precede hypertension, it was hypothesized 
that reversing these conditions could restore dopamine D1 receptor function 
(210). Umrani et al. (210) have reported that treating the obese Zucker rats with 
an insulin sensitizer (rosiglitazone) reduces insulin levels, normalizes blood 
pressure, restores euglycemia and restores both inhibition of Na+/K+ ATPase by 
dopamine and dopamine D1 receptor number at the membrane. Trivedi et al 
(208, 209) have confirmed that natriuresis in response to dopamine D1 receptor 
stimulation is impaired in these rats and rosiglitazone treatment restores the 
natriuretic response by restoring receptor-G protein coupling. 
Phosphorylation of G protein-coupled receptors (GPCRs), including dopamine 
D1 receptors, by G protein-coupled receptor kinases (GRKs) causes uncoupling 
of GPCRs from G proteins as well as receptor downregulation (174).  
Hyperphosphorylation of dopamine D1 receptors may contribute to their defective 
coupling to G proteins as well as their downregulation observed in obese Zucker 
rats. Rosiglitazone restores dopamine D1 receptor function by reducing its 
hyperphosphorylation (208). GRK2 and GRK4 are potential mediators of 
dopamine D1 receptor hyperphosphorylation. GRK4 expression is increased in 
obese Zucker compared to their lean counterparts and rosiglitazone prevents this 
increase in expression (208). While GRK2 expression is similar in both obese 
and lean Zucker rats, its translocation to the membrane is increased in obese 
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Zucker rats (208). Rosiglitazone treatment reverses this membrane translocation 
of GRK2 in obese rats (208). Since rosiglitazone reverses the hyperinsulinemia 
and hyperglycemia observed in obese rats, it is possible that hyperinsulinemia 
and hyperglycemia are in part responsible for uncoupling of dopamine D1 
receptors from G proteins and loss of dopamine D1 receptor mediated natriuresis 
and inhibition of Na+/K+ ATPase in these rats. Studies in other animal models 
and cell culture also support the role of hyperglycemia (42, 142) and 
hyperinsulinemia (2, 25, 26, 29) in impairment of dopamine D1 receptor function, 
decreased sodium excretion and development of hypertension.  
While these studies provide evidence for a strong association between 
hyperinsulinemia and development of dopamine D1 receptor function leading to 
development of hypertension, role of other factors cannot be discounted. For 
example, insulin sensitizers (pioglitazone and troglitazone) apart from lowering 
insulin levels can also reduce oxidative stress (59, 83). It is possible that the 
blood pressure lowering effects of insulin sensitizers are secondary to lowering of 
oxidative stress and not necessarily due to reversal of hyperinsulinemia (59, 83). 
2.5.2 Role of oxidative stress and redox sensitive transcription factor nuclear 
factor κ B (NFκB): 
Oxidative stress results from an imbalance between the generation of reactive 
oxygen species (ROS, like •O2-, •OH, •ONOO-, H2O2) and their scavenging by 
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antioxidant mechanisms (88). Sources for ROS generation include but are not 
limited to mitochondria, NAD(P)H oxidases, xanthine oxidases, and uncoupled 
nitric oxide synthases (88). Antioxidant mechanisms may involve the conversion 
of highly reactive superoxide (•O2-) to less reactive H2O2 by superoxide-
dismutase, neutralization of H2O2 by catalases or glutathione peroxidases to 
water or preferential oxidation of reduced glutathione (GSH) to oxidized 
glutathione (GSSG) to prevent oxidation of structural and functional proteins (88). 
Excess production of ROS and/or a decrease in activity or levels of antioxidant 
components can contribute to the imbalance and increased ROS levels (79, 80, 
88). The resulting excess of ROS can modify structural and functional proteins, 
DNA and other components of the cell leading to alteration of their function and 
ultimately altering the cell physiology (88). In addition, ROS or their byproducts 
like isoprostanes (that are used as markers of oxidative stress) can themselves 
act as signaling molecules and contribute to alteration of cell physiology (23, 88, 
153, 154). An increasing body of evidence indicates that oxidative stress plays a 
major role in pathogenesis of a variety of diseases including neurodegenerative 
diseases, cardiovascular diseases and diabetes (46, 61, 79, 80, 85, 118, 205, 
214). Oxidative stress is present in both obese humans and animal models of 
obesity and has been implicated in the development obesity related comorbidities 
including hypertension (58, 82, 107, 128, 145, 159, 178, 179, 182, 198). 
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Obese Zucker rats also display oxidative stress (32). Treatment of obese Zucker 
rats with the anti-oxidant tempol (4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl) 
reduces oxidative stress, reduces hyperinsulinemia, normalizes blood pressure, 
and restores renal dopamine D1 receptor mediated natriuresis  and inhibition of 
Na+/K+ ATPase by restoring membrane density of renal dopamine D1 receptors 
and their coupling with G-proteins (32). Similarly, treatment with lipoic acid 
(another antioxidant) was able to decrease oxidative stress, reduce membrane 
translocation of GRK2 and restore renal dopamine D1 receptor mediated 
inhibition of Na+/K+ ATPase and dopamine D1 receptor-G protein coupling (31). It 
is difficult to draw a cause and effect relationship between oxidative stress and 
dopamine D1 receptor dysfunction, because tempol and other antioxidants also 
reverse hyperglycemia and hyperinsulinemia (21, 32). 
However, other studies indicate that oxidative stress can impair dopamine D1 
receptor mediated natriuresis and inhibition of Na+/K+ ATPase irrespective of 
obesity, hyperglycemia or hyperinsulinemia (18, 27, 30, 64, 144). Asghar et al. 
(18) have shown that oxidative stress induced by hydrogen peroxide (H2O2) 
treatment causes hyperphosphorylation of renal dopamine D1 receptors and 
impairment of dopamine D1 receptor mediated inhibition of Na+/K+ ATPase in 
proximal tubular cultures from Sprague Dawley rats. In addition, they showed 
that PKC mediated membranous translocation of GRK2 is involved in 
hyperphosphorylation of dopamine D1 receptor in H2O2 treated cultures (18). 
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Fardoun et al (64) have reported an impairment of dopamine D1 receptor 
function and coupling to G proteins in old Fischer344 rats. Further, Fardoun et al. 
(63) have shown that nuclear translocation of NFκB following oxidative stress, 
increases PKC activity leading to membranous translocation of GRK2 and 
subsequent dopamine D1 receptor hyperphosphorylation. Inhibiting nuclear 
translocation of NFκB prevents the increase in PKC activity and PKC dependent 
membranous translocation of GRK2 and restores dopamine D1 receptor 
mediated inhibition of Na+/K+ ATPase (63). Similarly, treatment of Sprague 
Dawley rats with the pro-oxidant buthionine sulfoxime (BSO) causes oxidative 
stress leading to impairment of dopamine D1 receptor mediated inhibition of 
Na+/K+ ATPase and natriuresis and development of salt sensitive hypertension 
(27, 30). This impairment is associated with increased nuclear translocation of 
NFκB, increased PKC activity, increased GRK2 membranous translocation, renal 
dopamine D1 receptor hyperphosphorylation, impaired receptor-G protein 
coupling and receptor downregulation (27, 30). Supplementing these pro-oxidant 
treated rats with the antioxidant tempol reverses the above defects and restores 
dopamine D1 receptor mediated inhibition of Na+/K+ ATPase and natriuresis and 
prevents the development of salt sensitive hypertension (27, 30). 
Therefore, the above studies support the concept that oxidative stress may 
contribute to the impairment of renal dopamine D1 receptor function and 
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development of obesity associated hypertension. In addition, augmenting 
antioxidant mechanisms may provide a viable option to reduce oxidative stress, 
restore renal dopamine D1 receptor function and to attenuate hypertension. 
2.6 Role of exercise: 
Exercise is recommended as a lifestyle modification based on beneficial effects 
in terms of decreasing mortality and delaying the progression of a number of 
cardiovascular complications associated with disease states including obesity, 
hypertension and diabetes (1, 78, 106, 130). Exercise in both normal and 
overweight subjects has generally been associated with moderate decreases in 
blood pressure (220) improved insulin sensitivity and moderate reductions in 
blood glucose levels (166, 197). However, the effect of exercise on blood 
pressure, insulin sensitivity and blood glucose levels in both humans and animal 
models exhibiting metabolic syndrome is inconclusive. These studies that show 
either modest improvements or no effect of exercise on the above parameters 
have been elaborated under the discussion section along with the explanation of 
our results. Regardless, the amount of literature dedicated to understanding the 
mechanisms involved is very limited. It will be beneficial to understand the 
mechanisms by which exercise achieves or fails to achieve the improvements 
mentioned above. Specifically, the effect of exercise on renal dopamine D1 
receptor function and sodium homeostasis in obesity needs to be explored. 
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In terms of oxidative stress, acute effect of exercise is to actually increase the 
production of ROS (181).  Despite this, exercise reduces oxidative stress in the 
long term (119, 181). Since exercise can augment physiological anti-oxidant 
mechanisms (48, 169), it is possible that exercise mediated reductions in 
oxidative stress result from augmentation of antioxidant defenses (119, 181). 
Asghar et al (19) have shown in 23 month old Fischer344 rats that exercise 
augments antioxidant defenses, reduces oxidative stress and restores renal 
dopamine D1 receptor function. However, it is not known if exercise from an early 
age can prevent impairment of dopamine D1 receptor function and development 
of obesity and hypertension in obese Zucker rats. 
2.7 Role of calorie restriction: 
Restricting caloric intake to maintain energy balance is recommended as lifestyle 
modification based on beneficial effects in terms of decreasing mortality, 
increasing longevity and delaying the progression of a number of cardiovascular 
complications associated with disease states including obesity, hypertension and 
diabetes (1, 78, 130, 202). Caloric restriction in healthy non-obese individuals 
has been shown to decrease the risk for cardiovascular disease (134). Caloric 
restriction to reduce weight in hypertensive patients is associated with 
improvement of insulin sensitivity and a reduction of blood pressure associated 
with weight loss (155, 160). Recently, Metcalf et al (148) suggested that physical 
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inactivity is a result rather than a cause for obesity and that interventions aimed 
at reducing weight should focus on reducing caloric intake. 
Hyperphagia in obese Zucker rats and other models of obesity, while not the sole 
determinant of obesity, is a major contributor to the acceleration of weight gain 
(16, 201). Caloric restriction in these rats leads to a decrease in weight gain (201, 
225). However, even when the calories are restricted to levels comparable to 
lean controls, the drastic decrease in weight gain is not associated with a drastic 
decrease in fat accumulation relative to body weight (101, 201, 225). This might 
be related to a compensatory decrease in energy expenditure to favor fat storage 
in response to calorie restriction (101, 125). 
There is disagreement regarding the effect of caloric restriction on 
hyperinsulinemia. While some studies report that hyperinsulinemia in these rats 
is responsive to caloric restriction (22, 141), others indicate that it is not 
responsive (52, 129, 183). The differences between these studies can be 
reconciled based on the level of caloric restriction and the age at which restriction 
is initiated. Studies employing caloric restriction at levels comparable to that of 
lean rats achieved a significant reduction (~50%) in insulin levels (22, 141). 
Further, in studies that used a lower level of restriction and did not report a 
significant decrease in insulin levels, a trend towards decrease was noticed (52, 
183). In addition, Maddox et al (141) report that caloric restriction decreases 
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insulin levels only if initiated between six to twelve weeks of age. Also, maximum 
benefit is evident when caloric restriction is initiated at six weeks of age (141). 
Therefore, restricting caloric intake in obese Zucker rats to lean levels staring at 
an early age offers a means to reduce hyperinsulinemia. 
Caloric restriction in humans, including overweight and obese subjects, has been 
associated with a decrease in oxidative stress (120, 200, 211). However, this 
beneficial effect of caloric restriction is diminished in diabetic obese subjects 
(200). Caloric restriction has been reported to lower oxidative stress in animal 
models also (39, 123, 224). However, caloric restriction in a mice model of 
amyotrophic lateral sclerosis paradoxically increases oxidative stress, hastens 
disease progression and increases mortality (173). Therefore, the effect of caloric 
restriction on oxidative stress can be modified by disease states and in fact be 
detrimental in some cases. In obese Zucker rats, we are aware of a single study 
reporting a decrease in blood malondialdehyde (MDA) levels (a marker of 
oxidative stress) with caloric restriction (129). 
Literature addressing the effect of caloric restriction on blood pressure in obese 
Zucker rats is limited. Kurtz et al (131) reported that restricting caloric intake to 
lean levels in these rats for four weeks decreases weight gain and cumulative 
sodium retention but does not lead to decrease in blood pressure. In contrast, 
Maddox et al (141) reported that starting caloric restriction at an early age delays 
Page 23 of 152 
the development of hypertension in these rats. In addition, they reported a 
significant correlation of blood pressure with body weight and insulin levels (141). 
The reason for the different observations could be that different techniques were 
used to measure blood pressure. While Kurtz et al (131) reported arterial blood 
pressure using intra-femoral catheters, Maddox et al (141) reported systolic 
blood pressure using tail cuff method. Both studies measured blood pressure in 
conscious animals. The intensity of caloric restriction or the age at which caloric 
restriction is initiated cannot be the reason for the differences since both started 
restriction at 5-6 weeks of age and employed restriction to lean levels. We are 
not aware of any report in these rats where the effect of caloric restriction on 
dopamine D1 receptor function was studied. 
Therefore, it is not known if caloric restriction mediated reductions in insulin 
levels and/or oxidative stress can restore dopamine D1 receptor function and 
prevent or attenuate the development of hypertension in obese Zucker rats. 
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3 MATERIALS AND METHODS 
3.1 STUDIES AT THREE WEEKS OF AGE: 
3.1.1 PROTOCOL FOR STUDIES AT THREE WEEKS OF AGE: 
Three-week-old rats were used for the experiments described below. Three-
week-old rats were used because the rats are weaned at this age and they do 
not express the obese phenotype until five to six weeks of age. The University of 
Houston Animal Care and Use Committee approved all experimental protocols. 
Homozygous Zucker Leprfa/fa (obese Zucker) and Zucker Lepr+/+ (lean Zucker) 
rats were identified by genotyping of Zucker pups at fifteen days of age and they 
were weaned at nineteen days of age (Harlan Sprague Dawley Inc., Indianapolis, 
IN). Subsequently, the rats were obtained by the University of Houston Animal 
Care facility at twenty-one days of age and were maintained with a 12hr light-
dark cycle and provided free access to tap water and standard rat chow 
containing 0.4% sodium (Labdiet® 5001, Purina Mills, St. Louis, MO). The rats 
were allowed two days to acclimate before initiating any experimental 
procedures. 
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3.1.2 SURGICAL PROCEDURE FOR MEASUREMENT OF BLOOD 
PRESSURE AND TISSUE COLLECTION: 
Surgical procedures and tissue collection were performed as described earlier 
(49). Briefly, rats were fasted overnight and anesthetized with Inactin® (100-150 
mg/Kg, i.p). Tracheotomy was performed to facilitate breathing. Right carotid 
artery was catheterized and following 30 min of stabilization after surgery, 
systolic and diastolic blood pressures were recorded using a Statham P23AC 
pressure transducer connected to a Grass Polygraph (model 7D, Grass 
Instrument Company, Quincy, MA).  Mean arterial pressure (MAP) was 
calculated using the formula below. 
MAP = [(SBP- DBP)/3] + DBP 
After measurement of blood pressure, blood samples were collected from carotid 
artery in EDTA coated tubes (BD Diagnostics, Franklin Lakes, NJ). Plasma was 
separated by centrifuging the blood at 1500g for 15 min at 4°C. A midline 
abdominal incision was made and bladder urine was collected. Blood, plasma 
and urine samples were stored at -80ºC until analysis. The samples were 
analyzed using commercially available kits and were treated appropriately before 
storage as directed by the kit manufacturers. 
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3.1.3 MEASUREMENT OF BLOOD GLUCOSE AND LIPID PROFILE: Blood 
glucose and lipid profile were measured using a glucose analyzer (Roche 
Diagnostics, Indianapolis, IN) and Cardiochek-PA® (Polymer Technology 
Systems, Indianapolis, IN) respectively.  
3.1.4 MEASUREMENT OF FASTING PLASMA INSULIN AND INSULIN 
SENSITIVITY: 
Insulin was measured in plasma samples by a radioimmunoassay (RIA) using a 
sensitive rat insulin RIA kit®, (cat. # SRI-13K, Linco Research, St. Charles, MO). Plasma 
samples (20µl) were incubated in glass tubes with 380µl of assay buffer (0.05M 
phosphosaline, pH 7.4, containing 0.025M EDTA, 0.08% sodium azide, 1% RIA grade 
bovine serum albumin [BSA]) and rat insulin antibody (Guinea pig anti-rat insulin serum 
in assay buffer) at 4°C for 24hrs. After 24hrs, 125I-Insulin (specific activity 367 µCi/µg) in 
label hydrating buffer (assay buffer containing normal Guinea pig IgG as carrier) was 
added and incubated for another 24hrs at 4°C followed by addition of 1ml ice-cold 
precipitating reagent (Goat anti-Guinea pig IgG serum, 3% poly ethylene glycol (PEG) 
and 0.05% triton X-100 in 0.05M phosphosaline, 0.025M ethylene-diamine-tetra-acetic 
acid (EDTA), 0.08% sodium azide). The tubes were incubated for 20min at 4°C and 
centrifuged at 3000g for 40min at 4°C. Following centrifugation, the supernatant was 
decanted and pellets were used to measure radioactivity using a gamma counter 
(Beckman Coulter, Brea, CA). Standards (0.02-1.0ng/ml purified rat insulin), non-specific 
binding and total binding (Bo) of 125I-Insulin were used to generate a standard curve and 
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used to quantify insulin in samples and expressed as ng/ml of plasma. Insulin 
sensitivity was assessed using quantitative insulin sensitivity check index 
(QUICKI) (156). 
QUICKI=1/ [log (fasting insulin, µU/ml) X log (fasting glucose, mg/dl)] 
3.1.5 PREPARATION OF RENAL PROXIMAL TUBULES: 
3.1.5.1 Preparation of renal cortical tubular suspension: 
After collecting blood and urine samples, the aorta was catheterized below the 
renal arteries. Celiac and superior mesenteric arteries were tied to achieve 
selective renal perfusion. Subsequently, the kidneys were perfused with Krebs–
Henseleit buffer A (KHB-A, pH 7.4) (Table 1), maintained at 37ο C with a flow rate 
of 4ml/min, until the kidneys were clear of blood. Concurrent with the initiation of 
perfusion a ligature was placed on the aorta above the kidneys to prevent re-
entry of blood into the kidneys.  Subsequently, the kidneys were digested in-situ 
by perfusing with enzyme solution (Collagenase type IV, 230U/ml and 
Hyaluronidase type III 250 U/ml in 40 ml KHB-A).  Kidneys were excised, 
decapsulated, cleared of fat and connective tissue, and were weighed after 
blotting out excess moisture. Kidneys were cut sagitally into two equal halves 
and cortex was separated by cutting at the cortico-medullary junction using 
scissors. The cortex was chopped into fine pieces and incubated at 37ο C in 20ml 
of enzyme solution (Collagenase type IV, 460U/ml and Hyaluronidase type III 
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500 U/ml in KHB-A) under 95% O2: 5% CO2 for 25-30 min.  The suspension was 
filtered through a nylon mesh (mesh size 105 µm, Spectrum medical Industries, 
Los Angeles, CA). The filtrate was centrifuged in a swinging bucket rotor 
(SX4250 rotor, Beckman Coulter, Brea, CA) at 50g for 2 min to obtain a pellet 
which was resuspended in ice cold KHB buffer B (KHB-B, pH 7.4)(Table 1). The 
suspension in KHB-B was washed thrice by centrifugation at 250g for 5min and 
resuspended with KHB-B to remove residual enzyme solution. This cortical 
tubular suspension was used to prepare renal proximal tubules as detailed below 
in section 3.1.5.2. 
3.1.5.2 Enrichment of renal proximal tubules: 
Renal proximal tubules were enriched using 20% ficoll gradient in KHB-B. 
Cortical tubular suspension (15 ml) was placed as a layer over 5ml of 20% ficoll 
in a 50 ml centrifuge tube and centrifuged in a swinging bucket rotor (SX4250 
rotor, Beckman Coulter, Brea, CA) at 4ο C at 250g for 15 min. The layer resulting 
at the ficoll-KHB-B interface was collected and washed thrice by resuspension in 
KHB-C (Table 1, pH 7.4) and centrifugation at 250g for 5 minutes (Chen et al., 
1993). 
 
 
Page 29 of 152 
Table 1: Composition of buffers used in preparation of renal proximal 
tubules 
 KHB A (mM) KHB B (mM) KHB C (mM) 
NaCl 118.0 118.0 118.0 
NaHCO3 27.2 27.2 27.2 
KCl 4.0 4.0 4.0 
CaCl2 1.25 0.0 1.25 
MgCl2 1.2 0.12 1.2 
KH2PO4 1.0 1.0 0.0 
Glucose 5.0 5.0 5.0 
HEPES 10.0 10.0 10.0 
 
3.1.6 TEST FOR RENAL PROXIMAL TUBULAR VIABILITY: 
Renal proximal tubules were tested for viability using the trypan blue exclusion 
test as described earlier (49). In Brief, an aliquot of renal proximal tubular 
suspension was incubated with trypan blue solution (0.15% in KHB-A) for 10min 
and placed on a glass slide. The slide was observed under a microscope at 10X 
magnification. At least 95% of the renal proximal tubules excluded trypan blue for 
the preparation to be considered viable and fit for use in further studies. 
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3.1.7 MEASUREMENT OF Na+/K+ ATPASE ACTIVITY: 
Freshly prepared renal proximal tubular suspensions (1mg protein/ml) were 
incubated with the selective D1 receptor agonist SKF38393 (10-9M, 10-8M and 
10-7 M) or vehicle (O.1% Na metabisulfite) for 15 min at 37ο C. The SKF38393 or 
vehicle treated tubules were permeabilized by rapid freezing and thawing in a dry 
ice-acetone bath. To measure total Na+/K+ ATPase activity, 100 µl (1µg/ µl) of 
treated renal proximal tubular suspension was incubated at 37ο C for 15 min in a 
reaction mixture (final volume 1.025 ml) containing 37.5mM imidazole, 70mM 
NaCl, 5mM KCl, 1mM Na EDTA, 5mM MgCl2, 6mM NaN3, 75mM Tris-HCl. The 
reaction was initiated using 4mM ATP. Ouabain-insensitive ATPase activity was 
measured in the presence of ouabain (1mM). The reaction was terminated by 
adding 50µl of ice-cold trichloroacetic acid. Activity was quantitated by measuring 
inorganic phosphate (Pi) colorimetrically as described by Taussky and Shorr 
(1953).  Briefly, 150 µl of the reaction mixture was incubated at room temperature 
with 150 µl of ferrous sulphate-molybdate reagent (5% FeSO4 in 9 ml water + 1 
ml of 10% ammonium molybdate in 10N H2SO4) and the resulting color was 
spectrophotometrically measured at 740nM. Na+/K+ ATPase activity was 
calculated as the difference between total and ouabain-insensitive ATPase 
activity. The inhibition of Na+/K+ ATPase activity upon selective dopamine D1 
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receptor stimulation was expressed as a percentage over the basal Na+/K+ 
ATPase activity (activity in vehicle treated tubules) (Chen et al., 1993). 
3.1.8 PREPARATION OF RENAL PROXIMAL TUBULAR MEMBRANES: 
Renal proximal tubules were homogenized in homogenization buffer (10mM Tris 
HCl, 250mM sucrose, 2mM phenyl methyl sulfonyl fluoride (PMSF), Complete™ 
protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN), pH 7.4) using a 
Wheaton homogenizer and centrifuged at 2500g to settle nuclear and cell debris. 
The supernatant was collected as the renal proximal tubular homogenate. An 
aliquot of the homogenate obtained in the above step was centrifuged at 38,000g 
for 30 min at 4ο C to obtain a membrane pellet and the supernatant cytosolic 
fraction. The membrane pellet was resuspended in homogenization buffer and 
used for [3H]SCH23390 binding and [35S]GTPγS binding. 
3.1.9 [3H] SCH23390 BINDING FOR DOPAMINE D1 RECEPTOR: 
Total  [3H] SCH23390 binding was determined by incubating membrane samples 
(50µg) with 20nM [3H]SCH23390 (specific activity 86 Ci/mmol, Perkin Elmer, 
Shelton, CT) and binding buffer (50mM Tris-HCl, 2mM MgCl2, 0.2 mM sodium 
metabisulfite, 0.2mM phenyl methyl sulfonyl fluoride (PMSF), pH 7.4) to a final 
volume of 250µl. Non-specific binding of [3H]SCH23390 was determined 
separately by incorporating unlabeled SCH23390 (10µM) in the reaction mixture. 
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The reaction was carried out in MultiScreen-FC, 96 well filter plates with 1.2 µm 
FC glass fiber filters (Millipore, Billerica, MA) for 120min at 25ο C. The reaction 
was stopped by addition of 100µl ice-cold stop solution (50mM Tris-HCl, 2mM 
MgCl2, pH 7.4) and rapid filtration using Multiscreen Resist vacuum manifold kit 
(Millipore, Billerica, MA). The wells were washed four times by addition of 300 µl 
ice-cold stop solution followed by filtration. Filters were extracted overnight in 
liquid scintillation cocktail (Ready Safe Liqscint, VWR International, Suwanee, 
GA) and radioactivity was measured using a liquid scintillation counter (LS 6500, 
Beckman Coulter, Brea, CA). Specific binding was calculated as the difference 
between total and non-specific binding and was used to quantify dopamine D1 
receptor number per mg protein. 
3.1.10 [35S] GTPγS BINDING: 
Membrane samples (5µg), prepared as detailed above (section 3.1.9), were 
incubated with [35S]GTPγS (final concentration of 0.6nM, specific activity 1250 
Ci/mmol), in presence of SKF38393 (1nM) and guanosine diphosphate (10µM) to 
a final volume of 90µl in binding buffer (25mM HEPES, 15mM MgCl2, 1mM 
EDTA, 1mM dithiothreitol, 100mM NaCl, pH 8.0). SKF38393 was excluded to 
determine basal [35S]GTPγS binding. Unlabeled GTPγS (100µM) was 
incorporated in the reaction mixture to determine non-specific binding. The 
reaction was carried out in MultiScreen-FC, 96 well filter plates with 1.2 µm FC 
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glass fiber filters (Millipore, Billerica, MA) for 60min at 30ο C. The reaction was 
terminated by addition of filtering solution (20mM Tris-HCl, 100mM NaCl and 
25mM MgCl2) and rapid filtration using Multiscreen Resist vacuum manifold kit 
(Millipore, Billerica, MA). The wells were washed four times by addition of 300 µl 
ice-cold filtering solution followed by filtration as above. Filters were extracted 
overnight in liquid scintillation cocktail (Ready Safe Liqscint, VWR International, 
Suwanee, GA) and radioactivity was measured using a liquid scintillation counter 
(LS 6500, Beckman Coulter, Brea, CA). Specific binding was calculated as the 
difference between total and non-specific binding and was used to quantify 
[35S]GTPγS binding per mg protein. 
3.1.11 IMMUNOBLOTTING FOR G PROTEINS: 
Renal proximal tubular homogenates were supplemented with Laemmli buffer 
(62.5mM Tris-HCl, 10% glycerol, 2% sodium dodecyl sulfate (SDS) and 2.5% 2-
mercapto-ethanol and bromophenol blue) to prepare samples for electrophoresis. 
The samples (10µg) were resolved by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transblotted onto a polyvinylidene fluoride 
(PVDF) membrane (Immobilon-P®, Millipore, Billerica, MA). The membrane was 
blocked for 1hr with 5% fat free milk in phosphate buffered saline-tween (PBST) 
followed by incubation with anti-Gsα-subunit rabbit polyclonal IgG or anti-Gq/11α-
subunit rabbit polyclonal IgG (Calbiochem, San Diego, CA) for 15hrs at 4°C. The 
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membrane was washed with PBST thrice for 10min each and incubated in 
horseradish peroxidase (HRP) linked goat anti-rabbit IgG (Santacruz 
Biotechnology, Santacruz, CA) for 1hr. The membrane was again washed thrice 
(10 min each) with PBST. G protein bands were visualized with western blotting 
luminol reagent® (Santacruz Biotechnology, Santacruz, CA) on X-ray film and 
densitometrically quantified using AlphaInnotech® imaging software (Cell 
Biosciences, Santa Clara, CA). 
3.1.12 OXIDATIVE STRESS MARKERS: 
3.1.12.1 MEASUREMENT OF PROTEIN CARBONYLATION: 
Protein carbonylation was measured using OxyBlot® protein oxidation detection 
kit (Millipore, Billerica, MA) as per the manufacturer’s protocol. Two separate 
aliquots of renal proximal tubular homogenate (20µg protein) were denatured by 
addition of equal volume of 12% sodium dodecyl sulfate (SDS). One aliquot was 
used for derivatization to 2,4-dinitrophenylhydrazone (DNP-hydrazone) by 
incubation with 2,4-dinitrophenylhydrazine (DNPH) and the other was incubated 
with derivatization control solution and used as a derivatization control. The 
derivatization reaction was terminated after 15min by addition of 7.5µl 
neutralization solution to both aliquots. Both the derivatized samples and 
derivatization controls were subjected to SDS-PAGE and transblotted onto PVDF 
membranes. Membranes with transblotted proteins were blocked with 1% bovine 
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serum albumin (BSA) in PBST and then incubated for 1hr at 25°C with antibody 
specific to DNP-hydrazone. The membranes were washed three times (10min 
each) followed by incubation with HRP-linked antibody for 1hr at 25°C. Following 
washing, the derivatized proteins were visualized with western blotting luminol 
reagent® (Santacruz Biotechnology, Santacruz, CA) on X-ray film and 
densitometrically quantified using AlphaInnotech® imaging software (Cell 
Biosciences, Santa Clara, CA). 
3.1.12.2 MEASUREMENT OF PLASMA AND URINARY 8-ISOPROSTANE: 
8-isoprostane was measured by a competitive enzyme immunosorbent assay 
(EIA) using 8-isoprostane EIA kit® (Cayman Chemical Company, Ann Arbor, MI) 
as per the manufacturer’s protocol. Fresh plasma and urine samples were 
supplemented with 0.005% butylated hydroxytoluene (BHT) and 10µM 
indomethacin and stored at -80°C. Urine samples were diluted 1:50 with EIA 
buffer provided with the kit while plasma samples were used without dilution. 8-
isoprostane standards (0.8-500pg/ml) and urine and plasma samples (50µl) were 
incubated in a 96 well plate with 8-isoprostane-acetylcholine-esterase (AChE) 
tracer and 8-isoprostane specific rabbit antiserum for 18hrs at 4°C. Any unbound 
reagents were washed and the plate was incubated with 5,5’-Dithiobis-2-
nitrobenzoic acid (DTNB, Ellman’s reagent) for 90min. Absorbance of the 
resulting color was measured at a wavelength of 410nm and used for 
Page 36 of 152 
quantification as per kit manufacturer’s recommendations. Urinary 8-isoprostane 
content was normalized with creatinine levels. Creatinine levels were determined 
as described below in section 3.2.8. 
3.1.12.3 MEASUREMENT OF PROTEIN NITROSYLATION: 
Samples for electrophoresis were prepared by supplementing renal proximal 
tubular homogenates with Laemmli buffer (62.5mM Tris-HCl, 10% glycerol, 2% 
sodium dodecyl sulfate (SDS) and 2.5% 2-mercapto-ethanol and bromophenol 
blue). The samples (10µg) were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transblotted onto a 
polyvinylidene fluoride (PVDF) membrane (Immobilon-P®, Millipore, Billerica, 
MA). The membrane was blocked for 1hr with 1% bovine serum albumin (BSA) in 
phosphate buffered saline-tween (PBST) followed by incubation with HRP 
conjugated anti-nitrotyrosine (clone 1A6) IgG (Millipore, Billerica, MA). The 
protein bands were visualized with western blotting luminol reagent® (Santacruz 
Biotechnology, Santacruz, CA) on X-ray film and densitometrically quantified 
using AlphaInnotech® imaging software (Cell Biosciences, Santa Clara, CA). 
3.1.12.4 MEASUREMENT OF WHOLE BLOOD GLUTATHIONE LEVELS: 
Reduced (GSH) and oxidized (GSSG) glutathione were measured using 
BIOXYTECH® GSH/GSSG-412™ kit (OxisResearch™, Portland, OR). The kit 
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employs the enzymatic method described by Tietze (207). Briefly, GSSG is 
converted to GSH by glutathione reductase, which on reaction with 5,5’-Dithiobis-
2-nitrobenzoic acid (DTNB, Ellman’s reagent) develops color. The rate of color 
development, measured spectrophotometrically at 412nm, is used to quantify 
GSH and GSSG levels. Two separate aliquots of whole blood were stored at       
-80°C and used for determination of total (GSH + GSSG) glutathione levels and 
GSSG alone. The aliquot used to determine GSSG levels alone was treated with 
1-methyl-2-vinylpyridinium, a GSH scavenger, before storage at -80°C to prevent 
non-enzymatic conversion of GSH to GSSG. After thawing, both aliquots were 
extracted with 5% metaphosphoric acid and the resulting extracts were incubated 
with glutathione reductase and Ellman’s reagent for 5min. The chromogenic 
reaction was initiated by addition of NADPH and change of absorbance was 
measured for 3min at 412nm wavelength. Total glutathione (GSH+GSSG) and 
oxidized glutathione (GSSG) levels were quantified using rate curves generated 
using appropriate standards. GSH levels were calculated as the difference 
between total glutathione and GSSG levels. 
3.1.12.5 MEASUREMENT OF HEMEOXYGENASE-1 (HO-1) LEVELS: 
Hemeoxygenase-1 (HO-1) levels in plasma and renal proximal tubular 
homogenates were measured by a sandwich enzyme linked immunosorbent 
assay (ELISA), using rat HO-1 ELISA kit® (Assay Designs, Ann Arbor, MI) as per 
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the kit manufacturer’s protocol. Briefly, plasma or renal proximal tubular 
homogenates were incubated in 96 well plates pre-coated with anti-HO-1 mouse 
monoclonal antibody followed by incubation with rabbit polyclonal anti-HO-1 
antibody. Subsequently, the plate was incubated with HRP-linked anti-rabbit IgG 
followed by incubation with tetramethylbenzidine, an HRP-substrate, to develop a 
blue color. Color development was stopped by addition of an acidic stop solution 
and the resulting yellow color was quantified spectrophotometrically by 
measuring absorbance at 450nm. Appropriate standards were used to quantify 
HO-1 levels, as ng/ml in plasma and ng/mg protein in renal proximal tubular 
homogenates. 
3.1.12.6 MEASUREMENT OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY: 
Superoxide dismutase (SOD) activity in plasma and renal proximal tubular 
homogenates was measured using superoxide dismutase assay kit® (Cayman 
Chemical, Ann Arbor, MI). Renal proximal tubules were homogenized in SOD 
homogenization buffer (20mM HEPES, 1mM EGTA, 210mM mannitol, 70mM 
sucrose, pH 7.4) followed by centrifugation at 1500g for 5min at 4°C. The 
resulting supernatant was used as the renal proximal tubular homogenate. 
Plasma samples were diluted (1:5) in sample buffer (50mM Tris-HCl, pH 8.0). 
Bovine Cu/Zn SOD (0.025-0.25U) was used to generate a standard curve. 
Standards and samples (10µl) were incubated on an orbital shaker in a 96 well 
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plate with 200µl of tetrazolium salt solution in assay buffer (50mM Tris-HCl, 
0.1mM diethylenetriaminepentaacetic acid, 0.1mM hypoxanthine, pH 8.0) and 
20µl of xanthine oxidase at room temperature for 20min. The resulting yellow 
color was quantified by measuring absorbance at a wavelength of 450nm. SOD 
activity was expressed as Units/ml for plasma samples and Units/mg protein for 
renal proximal tubular homogenates. One unit of SOD was described by the kit 
manufacturer as the amount of enzyme required to exhibit dismutation of 50% 
superoxide radicals. 
3.1.13 MEASUREMENT OF NUCLEAR TRANSLOCATION OF NFκB: 
3.1.13.1 Separation of nuclear and cytosolic fractions: 
Renal proximal tubular nuclear and cytosolic fractions were prepared using NE-
PER™ Nuclear and Cytosplasmic Extraction Reagents kit® (Pierce 
Biotechnology, IL). Renal proximal tubules were homogenized in cytoplasmic 
extraction reagent® (CER) I, using a glass douncer followed by incubation with 
ice-cold CERII for 1min. The homogenate was centrifuged at 16,000g for 5min 
and the supernatant was saved as the cytosolic fraction. The pellet was 
resuspended in ice-cold nuclear extraction reagent (NER) and incubated on ice 
with vortexing at regular intervals for 40min followed by centrifugation at 16,000g 
for 10min and the supernatant was saved as the nuclear fraction. 
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3.1.13.2 Immunoblotting for NFκB: 
Samples for electrophoresis were prepared by supplementing nuclear and 
cytosolic fractions with Laemmli buffer (62.5mM Tris-HCl, 10% glycerol, 2% 
sodium dodecyl sulfate (SDS) and 2.5% 2-mercapto-ethanol and bromophenol 
blue). The samples (15µg) were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transblotted onto a 
polyvinylidene fluoride (PVDF) membrane (Immobilon-P®, Millipore, Billerica, 
MA). The membrane was blocked for 1hr with 5% fat free milk in phosphate 
buffered saline-tween (PBST) followed by incubation with anti-NFκB-p65 subunit 
rabbit polyclonal IgG (Calbiochem, San Diego, CA) for 18hrs at 4°C. The 
membrane was washed with PBST thrice for 10 min each and incubated in 
horseradish peroxidase (HRP) linked goat anti-rabbit IgG (Santacruz 
Biotechnology, Santacruz, CA) for 1hr. The membrane was again washed thrice 
(10 min each) with PBST and protein bands were visualized with western blotting 
luminol reagent® (Santacruz Biotechnology, Santacruz, CA) on X-ray film and 
densitometrically quantified using AlphaInnotech® imaging software (Cell 
Biosciences, Santa Clara, CA). 
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3.2 PROTOCOL FOR EXERCISE STUDY: 
3.2.1 ANIMALS AND EXERCISE PROTOCOL:  
Homozygous Zucker Leprfa/fa (obese Zucker) and Zucker Lepr+/+ (lean Zucker) 
rats were identified by genotyping of Zucker pups at fifteen days of age and they 
were weaned at nineteen days of age (Harlan Sprague Dawley Inc., Indianapolis, 
IN). Subsequently, the rats were obtained by the University of Houston Animal 
Care facility at twenty-one days of age and were maintained with a 12hr light-
dark cycle and provided free access to tap water and standard rat chow 
containing 0.4% sodium (Labdiet® 5001, Purina Mills, St. Louis, MO). The rats 
were allowed two days to acclimate before initiating any experimental 
procedures. The rats were randomly divided into four groups; lean sedentary, 
lean exercised, obese sedentary and obese exercised group. Lean exercised 
group was excluded from some studies specified below. The exercise group was 
subjected to treadmill exercise for eight weeks according to a previously reported 
protocol with some modifications (84). Briefly, the rats were exercised at 0º 
incline and a speed of 10 m/min for 1hr daily (5min breaks every 15min), five 
days a week. Body weights were recorded at the beginning of the study and 
weekly thereafter until the end of the study. The rats were placed in metabolic 
cages to measure food and water intake from fifth to eighth week of age. After 
eight weeks of exercise, at eleven weeks of age, the rats were used for the 
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experiments described below. Before any further experimental procedures were 
performed, the rats were rested for 48hrs after the last exercise session to 
eliminate interference from acute effects of exercise. 
3.2.2 SURGICAL PROCEDURE FOR MEASUREMENT OF BLOOD 
PRESSURE AND TISSUE COLLECTION: 
Surgical procedures were performed as described in section 3.1.2. Heart, liver, 
spleen, visceral fat and brain were cleared of connective tissue and weighed 
after blotting out excess moisture. Renal proximal tubules were prepared as 
described in section 3.1.5 above. The organs and tissues were stored at -80°C. 
3.2.3 MEASUREMENT OF BLOOD GLUCOSE AND LIPID PROFILE: 
Blood glucose and lipid profile were measured as described in section 3.1.3. 
3.2.4 MEASUREMENT OF FASTING PLASMA INSULIN AND INSULIN 
SENSITIVITY: 
Fasting plasma insulin and insulin sensitivity were measured as described in 
section 3.1.4. 
3.2.5 OXIDATIVE STRESS MARKERS: 
3.2.5.1 MEASUREMENT OF URINARY 8-ISOPROSTANE: 
Urinary 8-isoprostane was measured as described above in section 3.1.12.2. 
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3.2.5.2 MEASUREMENT OF MALONDIALDEHYDE (MDA) LEVELS: 
Malondialdehyde (MDA) levels were measured as thiobarbituric acid reactive 
substances (TBARS) using the method of Mihara and Urchiyama (150). Renal 
proximal tubules were homogenized in ice-cold 1.15% KCl, (pH 7.4) with a 
polytron homogenizer. The homogenate was centrifuged at 12000g for 5min and 
the supernatant was used for measurement of TBARS. A 1ml aliquot of the 
above supernatant (protein conc. 2mg/ml) was added to 2ml solution of 0.25N 
HCl, 15% trichloro-acetic acid and 0.375% 2-thiobarbituric acid. The reaction 
mixture was heated for 15 min in boiling water and after cooling was extracted 
with isobutanol. Absorbance of the isobutanol extract was measured 
spectrophotometrically at 535nm and quantified using the molar extinction 
coefficient of MDA (1.56 X 105 M-1 cm-1) and expressed as nmoles MDA/mg of 
protein. 
3.2.5.3 MEASUREMENT OF WHOLE BLOOD GLUTATHIONE LEVELS: 
Total glutathione levels were measured in whole blood samples as described 
above in section 3.1.12.4. 
3.2.5.4 MEASUREMENT OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY: 
Plasma and renal proximal tubular SOD activity was measured as described in 
section 3.1.12.6. 
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3.2.6 MEASUREMENT OF URINARY ALBUMIN EXCRETION: 
Urinary albumin was measured by an enzyme immuno-assay (EIA) using rat 
albumin EIA kit® (Cayman Chemical Company, Ann Arbor, MI) as per the 
manufacturer’s protocol. Briefly, 50µl of diluted urine samples (1:5000 in EIA 
buffer®) were incubated with rat albumin acetylcholine esterase (AChE) tracer® 
and rat albumin antiserum in a 96 well plate for 20hrs at 4°C. At the end of the 
incubation period, the plate was washed 5 times with wash buffer and 200µl of 
Ellman’s reagent was added to the wells to develop a yellow color. The color was 
quantified by measuring absorbance at a wavelength of 410nm. Standards (7.8-
1000ng/ml rat albumin), non-specific binding and total binding (Bo) of AChE 
tracer were used to generate a standard curve and to determine albumin 
concentrations (ng/ml). Albumin concentrations were normalized with creatinine 
levels and expressed as µg/mg of creatinine. Creatinine levels were measured as 
described below in section 3.2.8. 
Since there were no differences in measures of oxidative stress and other 
physiological parameters between the lean sedentary and lean exercised groups, 
lean exercised group was eliminated from the following studies. 
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3.2.7 MEASUREMENT OF NATRIURETIC RESPONSE TO SELECTIVE 
DOPAMINE D1 RECEPTOR AGONIST (SKF38393): 
A separate set of rats was used for the measurement of natriuretic response to 
SKF38393. Rats were fasted overnight and anesthetized with Inactin® (100 
mg/Kg, i.p). Tracheotomy was performed to facilitate breathing and right carotid 
artery was catheterized with PE-50 tubing to measure blood pressure (as 
described earlier) and to collect blood. The left jugular vein was catheterized 
using PE-50 tubing for infusing saline or drug. Normal saline was infused 
continuously throughout the experimental period to maintain stable urine output 
and to prevent dehydration of rats. For collecting urine, following midline 
laparotomy, the left ureter was catheterized with PE-10 tubing connected to 
tygon® tubing. 
Following a stabilization period of 45 minutes after initiation of saline infusion, 
urine and blood samples were collected for 5 consecutive 30 min periods (C1, 
C2, D, R1 and R2). The five consecutive collection periods are as follows: 
a. Two basal collection periods (basal 1, basal 2), during which saline 
alone was infused.   
b. Drug period, during which SKF 38393 (3µg/kg/min in saline) was 
infused. 
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c. Two recovery periods (R1 and R2), during which saline alone was 
infused. 
Plasma was separated by centrifuging the blood samples at 1500g for 15 
minutes at 4°C.  Sodium and creatinine concentrations were measured in both 
plasma and urine samples. Sodium concentrations were measured using a flame 
photometer (Model 2655-10, Cole Parmer Instrument Company, IL). Creatinine 
concentrations were measured using creatinine assay kit® (BioVision, Mountain 
View, CA), as described below in section 3.2.8. Creatinine clearance (CLcreatinine) 
was calculated using the formula given below and considered as a marker of 
glomerular filtration rate (GFR). Urinary sodium excretion (UNaV) and fractional 
excretion of sodium (FENa) were calculated using the formulae given below. 
 
FENa =  UNa V (µmol/min) X 100 
Plasma Na concentration (µmol/µl) X GFR (µl/min) 
 
UNa V (µmol/min)  = Urine flow (µl/min) X Urinary sodium concentration (µmol/µl) 
 
CLcreatinine = Urine flow (ml/min) X Urine creatinine concentration (mg/dl) 
Plasma creatinine concentration (mg/dl)  
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3.2.8 MEASUREMENT OF CREATININE LEVELS: 
Creatinine was measured by a colorimetric assay using creatinine assay kit® 
(BioVision, Mountain View, CA) as per the kit manufacturer’s protocol. The assay 
involves enzymatic conversion of creatinine to creatine and creatine to sarcosine. 
The oxidation product of sarcosine reacts with a probe® to generate color that 
was quantified by measuring absorbance at 570nm. Urine (1:100) and plasma 
(1:25) samples were diluted with assay buffer. Diluted samples and creatinine 
standards (2-10 nmoles) were incubated in a 96 well plate with the assay buffer®, 
creatininase, creatinase, enzyme mix® and probe®. The plate was incubated for 
1hr at 37°C and absorbance was measured at 570nm and used to quantify 
creatinine content using the standard curve. 
3.2.9 PREPARATION OF RENAL PROXIMAL TUBULES: 
Renal proximal tubules were prepared as described in section 3.1.5. 
3.2.10 TEST FOR RENAL PROXIMALTUBULAR VIABILITY: 
Renal proximal tubules were tested for viability as described in section 3.1.6. 
3.2.11 PREPARATION OF RENAL PROXIMAL TUBULAR MEMBRANES: 
Renal proximal tubular membranes were prepared as described in section 3.1.8. 
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3.2.12 [35S] GTPγS BINDING: 
[35S] GTPγS binding was measured in renal proximal tubular membranes as 
described in section 3.1.10 except that three different concentrations (1, 10 and 
100nM) of SKF38393 were used. 
3.2.13 MEASUREMENT OF NUCLEAR TRANSLOCATION OF NFκB:  
Nuclear translocation of the redox sensitive transcription factor NFκB was 
measured using the procedure described under section 3.1.13. 
3.3 PROTOCOL FOR CALORIC RESTRICTION STUDY: 
3.3.1 ANIMALS AND CALORIC RESTRICTION PROTOCOL: 
Homozygous Zucker Leprfa/fa (obese Zucker) rats were obtained at five weeks of 
age and were maintained with a 12hr light-dark cycle and provided free access to 
tap water and standard rat chow containing 0.4% sodium (Labdiet® 5001, Purina 
Mills, St. Louis, MO). The rats were allowed seven days to acclimate before 
initiating any experimental procedures. After acclimation, the rats were placed in 
metabolic cages and food and water intake was recorded daily for seven days to 
get a baseline reading. At seven weeks of age, the rats were randomly divided 
into two groups, ad libitum group and caloric restriction group. The ad libitum 
group was provided free access to standard rat chow and caloric restriction 
group was given 50% of the amount consumed by the ad libitum group. Both 
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groups were given free access to water. After eight weeks of caloric restriction (at 
15 weeks of age), blood samples were collected from the tail vein to measure 
insulin levels. Fasting plasma insulin levels were measured as described below 
in section 3.3.4. After ten weeks of caloric restriction (at 17 weeks of age), 
natriuretic response to SKF38393 and oxidative stress markers were measured 
as described below. 
3.3.2 SURGICAL PROCEDURE FOR MEASUREMENT OF BLOOD 
PRESSURE AND TISSUE COLLECTION: 
Surgical procedures were performed as described in section 3.1.2. Liver, spleen, 
visceral fat and heart were cleared of connective tissue and weighed after 
blotting out excess moisture. Renal cortical homogenates were prepared as 
described in section 3.1.5.1 above. The organs and renal cortical homogenates 
were stored at -80°C. 
3.3.3 MEASUREMENT OF BLOOD GLUCOSE AND LIPID PROFILE: 
Blood glucose and lipid profile were measured as described in section 3.1.3. 
3.3.4 MEASUREMENT OF FASTING PLASMA INSULIN AND INSULIN 
SENSITIVITY: 
Both ad libitum and caloric restriction group were fasted overnight and the tail 
vein was transiently catheterized with Surflo Winged Infusion Set™ 3.5 21gx3/4" 
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(Henry Schein, Melville, NY) to collect blood. The needle puncture was sealed 
with 3M-Vetbond™ 1469-SB (Henry Schein, Melville, NY) and betadine solution 
(Henry Schein, Melville, NY) was applied to the puncture area. Plasma was 
separated by centrifuging the blood at 1500g for 15 min at 4°C. Fasting plasma 
insulin and insulin sensitivity were measured as described in section 3.1.4. 
3.3.5 OXIDATIVE STRESS MARKERS: 
3.3.5.1 MEASUREMENT OF PROTEIN CARBONYLATION: 
Protein carbonylation was measured using renal cortical homogenates as 
described in section 3.1.12.1. 
3.3.5.2 MEASUREMENT OF PLASMA AND URINARY 8-ISOPROSTANE: 
Plasma and urinary 8-isoprostane were measured as described above in section 
3.1.12.2. 
3.3.5.3 MEASUREMENT OF PROTEIN NITROSYLATION: 
Renal cortical protein nitrosylation was measured by a competitive enzyme linked 
immunosorbent assay (ELISA) using a nitrotyrosine assay kit® (Millipore, 
Billerica, MA) according to the kit manufacturer’s protocol. White, high binding 96 
well plates were incubated with 100µl of nitrated BSA solution (5µg/ml) in 
carbonate buffer (15mM Na2CO3, 35mM NaHCO3, pH 9.5) for 20hrs at 4°C. The 
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plates were washed twice with Tween-20 supplemented tris-buffered-saline 
(TBS-T, 50mM Tris-HCl, 150mM NaCl, 0.05% Tween-20, pH 7.4) followed by 
washing with tris-buffered saline (TBS, 50mM Tris-HCl, 150mM NaCl, pH 7.4). 
The plate was incubated with 150µl of blocking buffer® for 1hr at 37°C to block 
nonspecific binding sites. After discarding the blocking buffer, 50µl of renal 
cortical homogenates (10µg/ml) or standards (0.1-1200µg/ml) were incubated 
with 50µl of anti-nitrotyrosine rabbit IgG for 1hr at 37°C. The plate was washed 
once with TBS-T and thrice with TBS. HRP-conjugated anti-Rabbit IgG (100µl) 
was added to wells and the plate incubated for 1hr at 37°C. The plate was again 
washed once with TBS-T and thrice with TBS followed by addition of 75µl of 
LumiGLO® chemiluminescent substrate. After incubation for 10min, the resulting 
luminescence was measured using a plate reader and used to quantify 
nitrotyrosine levels as pmoles/mg of protein. 
3.3.5.4 MEASUREMENT OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY: 
Plasma and renal cortical SOD activity was measured as described in section 
3.1.12.6. 
3.3.5.5 MEASUREMENT OF MALONDIALDEHYDE (MDA) LEVELS: 
Malondialdehyde (MDA) levels were measured in renal cortical homogenates as 
described in section 3.2.5.2. 
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3.3.6 MEASUREMENT OF NATRIURETIC RESPONSE TO SELECTIVE D1 
RECEPTOR AGONIST (SKF38393): 
Natriuretic response to the selective dopamine D1 receptor agonist SKF38393 
was measured as described in section 3.2.7. Sodium was measure using atomic 
absorption spectroscopy (AAnalyst 400 atomic absorption spectrometer, Perkin 
Elmer, Waltham, MA). 
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4. RESULTS: 
4.1 STUDIES AT THREE WEEKS OF AGE: 
The studies described in this section were performed in three-week-old Leprfa/fa 
Zucker (obese) rats and Lepr+/+ Zucker (lean) controls. Three-week-old Leprfa/fa 
Zucker (obese) rats and Lepr+/+ Zucker (lean) controls were identified by 
genotyping as they cannot be visually differentiated at this age. 
4.1.1 General physiological parameters of Leprfa/fa Zucker (obese) and 
Lepr+/+ Zucker (lean) rats at three weeks of age: 
At three weeks of age, Leprfa/fa Zucker (obese) rats cannot be visually 
differentiated from the Lepr+/+ Zucker (lean) controls and are of similar weight as 
their lean counterparts (Table 2). Kidney weight to body weight ratio was similar 
in both the groups (Table 2). Three weeks old Leprfa/fa Zucker (obese) rats 
display significantly higher levels of total cholesterol (Table 2), HDL cholesterol 
(Table 2) and triglycerides (Table 2). Mean arterial pressure in Leprfa/fa Zucker 
(obese) rats at three weeks of age is not significantly different from Lepr+/+ 
Zucker (lean) controls (fig. 1A). Fasting blood glucose levels are similar in both 
the groups (fig. 1B).  However, Leprfa/fa Zucker (obese) rats display significantly 
higher fasting plasma insulin levels (~2 fold) and decreased insulin sensitivity 
Page 54 of 152 
(measured using quantitative insulin check index, QUICKI) compared to their 
lean counterparts (fig. 1C and D respectively). 
4.1.2 Levels of oxidative stress markers at three weeks of age: 
4.1.2.1 Proximal tubular protein carbonylation: 
Three weeks old Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats displayed 
similar levels of renal proximal tubular protein carbonylation (fig. 2). Since no 
bands were detected for derivatization controls in both the groups (fig. 2, upper 
panel, lanes 1 and 3), the entire strip of protein bands was used for 
quantification. 
4.1.2.2 Plasma and urinary 8-isoprostane: 
Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats displayed similar levels of 
both plasma and urinary 8-isoprostane (fig. 3A and 3B respectively). 
4.1.2.3 Proximal tubular protein nitrosylation: 
Protein nitrosylation levels in renal proximal tubules were similar in both Lepr+/+ 
Zucker (lean) and Leprfa/fa Zucker (obese) rats at three weeks of age (fig. 4). 
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4.1.2.4 Whole blood glutathione levels: 
Lepr+/+ Zucker (lean) and Leprfa/fa Zucker (obese) rats displayed similar levels of 
both reduced glutathione (GSH) and oxidized glutathione (GSSG) (fig. 5A) and 
hence the ratio of GSH to GSSG was also similar (fig. 5B). 
4.1.2.5 Plasma and renal proximal tubular hemeoxygenase-1 levels: 
Plasma hemeoxygenase-1 (HO-1) levels were higher in Leprfa/fa Zucker (obese) 
rats (fig. 6A) but proximal tubular HO-1 levels were similar in both the groups (fig. 
6B). 
 4.1.2.6 Plasma and renal proximal tubular superoxide dismutase activity: 
Plasma superoxide dismutase (SOD) activity was similar in both the groups (fig. 
7A). However, SOD activity in proximal tubular homogenate was significantly 
decreased in Leprfa/fa Zucker (obese) compared to Lepr+/+ Zucker (lean) rats (fig. 
7B). 
4.1.3 Inhibition of renal proximal tubular Na+/K+ ATPase activity by 
SKF38393 at three weeks of age: 
At three weeks of age, SKF38393 inhibited renal proximal tubular Na+/K+ ATPase 
activity in a dose dependent manner in Lepr+/+ Zucker (lean) rats but failed to do 
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so in Leprfa/fa Zucker (obese) rats (fig. 8A). Basal Na+/K+ ATPase activity was 
found to be similar in both the groups (8B). 
4.1.4 Renal proximal tubular dopamine D1 receptor-G protein coupling at 
three weeks of age: 
Renal dopamine D1 receptor-G protein coupling, measured as stimulation of 
GTPγS binding in response to SKF38393, was significantly lower in Leprfa/fa 
Zucker (obese) rats when compared to Lepr+/+ Zucker (lean) rats (fig. 9A). Basal 
GTPγS binding (fig. 9B), and protein levels of the G proteins GSα (fig. 10A) and 
Gq/11α (fig. 10B) were similar in both the groups. 
4.1.5 Renal proximal tubular membrane Dopamine D1 receptor levels at 
three weeks of age: 
Renal proximal tubular membrane dopamine D1 receptor levels, measured using  
[3H]SCH23390 binding, were similar in both the Lepr+/+ Zucker (lean) and Leprfa/fa 
Zucker (obese) rats at three weeks of age (fig. 11). 
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4.1.6 Nuclear translocation of NFκB in renal proximal tubules at three 
weeks of age: 
Nuclear and cytosolic levels of NFκB in Leprfa/fa Zucker (obese) were similar to 
those in Lepr+/+ Zucker (lean) rats (fig. 12). In both groups, nuclear levels of 
NFκB were lower than cytosolic levels (fig 12). 
4.2 EFFECT OF EXERCISE: 
It has been suggested that starting a lifestyle intervention early in life might alter 
physiological processes that might be more difficult to alter at a later age. Hence, 
starting a lifestyle intervention at an early age could be more beneficial (130). 
Therefore, we subjected the rats to exercise from three weeks of age, for eight 
weeks, until the age of eleven weeks. The results described in this section are 
from studies performed at eleven weeks of age after eight weeks of exercise 
period. 
4.2.1 Effect of exercise on general physiological parameters: Obese rats 
consumed significantly higher amounts of food and water when compared to lean 
rats (fig. 13A and B respectively) from five to eight weeks of age. Exercise did not 
alter the intake of either food or water in both lean and obese rats (fig. 13A and B 
respectively). Obese rats displayed significantly higher body weights compared 
to lean rats from six weeks of age until eleven weeks of age (fig. 13C). Exercise 
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did not reduce the gain in body weight in both obese and lean rats (fig. 13C). 
After completion of exercise or sedentary protocol, obese sedentary rats 
displayed significantly higher blood pressure, fasting blood glucose levels, 
profound hyperinsulinemia (~9 fold) and decreased insulin sensitivity (QUICKI) 
when compared to lean rats (fig. 14 A, B, C and D respectively). Exercise had no 
effect on blood pressure, fasting blood glucose levels, insulin levels or insulin 
sensitivity in both lean and obese rats (fig. 14 A, B, C and D respectively). 
Triglyceride levels were significantly higher (~6 fold) in obese rats compared to 
lean rats (Table 3). Exercise significantly reduced triglyceride levels in obese rats 
but not lean rats (Table 3). Total cholesterol levels were similar in both obese 
sedentary and exercised groups (Table 3). Total cholesterol levels were 
undetectable, using the method employed, in lean rats.  HDL cholesterol was 
significantly higher in obese rats compared to lean rats (Table 3). While exercise 
did not affect HDL cholesterol levels in lean rats, it paradoxically reduced HDL 
cholesterol in obese rats (Table 3). However, the levels still remained 
significantly higher compared to lean rats (Table 3). Obese rats compared to lean 
rats, display a significantly higher body weight and fat to body weight ratio (Table 
3). Exercise did not alter the ratio in lean rats but paradoxically increased the 
ratio in obese rats by ~15% (Table 3). 
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Kidneys, heart, spleen and brain of obese rats showed significantly lower organ 
weight to body weight ratios compared to lean rats and exercise did not alter this. 
Liver to body weight ratios were similar in all the groups (Table 3). 
4.2.2 Effect of exercise on oxidative stress: 
4.2.2.1 Urinary 8-Isoprostane: 
Obese rats display increased levels of urinary 8-Isoprostane when compared to 
lean rats (fig. 15). Exercise decreased levels of urinary 8-Isoprostane in obese 
rats but did not affect levels in lean rats (fig. 15). 
4.2.2.2 Renal malondialdehyde (MDA): 
Obese rats display increased levels of renal MDA than lean rats (fig. 16). 
Exercise decreased levels of MDA in obese rats but did not affect levels in lean 
rats (fig. 16). 
4.2.2.3 Whole blood glutathione: 
Obese rats display decreased blood glutathione levels and exercise did not 
cause any changes in glutathione levels in both lean and obese rats (fig. 17). 
4.2.2.4 Plasma and proximal tubular superoxide dismutase (SOD): 
Obese rats also showed decreased superoxide dismutase (SOD) activity in both 
plasma (fig. 18A) and proximal tubular homogenates when compared to lean rats 
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(fig. 18B). Exercise augmented SOD activity in both plasma (fig. 18A) and 
proximal tubular homogenates (fig. 18B) of obese rats while the lean exercised 
group did not show any significant changes. 
4.2.3 Effect of exercise on urinary albumin excretion: 
Obese rats displayed ~20 fold higher urinary albumin excretion when compared 
to lean rats (fig. 19). Exercise decreased urinary albumin excretion by ~50% in 
obese rats but did not have any affect on lean rats (fig. 19). 
Since exercise did not change any of the above parameters tested in lean rats, 
the lean exercised group was excluded from the following studies. 
4.2.4 Effect of exercise on natriuretic response to SKF38393: Intravenous 
infusion of SKF38393 (3µg kg-1.body wt. min-1) increased urine flow, urinary 
sodium excretion (UNaV) and fractional excretion of sodium (FENa) in lean rats but 
not in obese rats (fig. 20, 21 and 22 respectively). Exercise increased diuresis in 
response to SKF38393 (fig. 20). However, it failed to restore the natriuretic 
response in obese rats since both urinary sodium excretion (UNaV) and FENa did 
not increase in response to SKF38393 infusion (fig. 21 and 22 respectively). 
Basal glomerular filtration rate (GFR) was similar in all the groups and SKF38393 
infusion did not alter GFR (fig. 23), blood pressure or heart rate. Lean rats 
showed a marginal decrease in GFR during recovery phase (fig. 23). 
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4.2.5 Effect of exercise on SKF38393 induced dopamine D1 receptor-G 
protein coupling: SKF38393 (1, 10 and 100nM) induced a concentration 
dependent increase in [35S]GTPγS binding in proximal tubular membranes from 
lean rats (fig. 24A). However, SKF38393 failed to elicit any significant 
[35S]GTPγS binding in both the sedentary and exercised obese rats (fig. 24A). 
Thus, obese rats display defective dopamine D1 receptor-G protein coupling and 
exercise fails to correct this defect in coupling. Basal [35S]GTPγS binding was 
similar in all the groups (fig. 24B) (lean sedentary, 229.0±9.32 fmoles/mg; obese 
sedentary, 259.1±16.92 fmoles/mg; obese exercised, 264.5±10.48 fmoles/mg). 
4.2.6 Effect of exercise on nuclear translocation of nuclear factor κ B 
(NFκB): Significantly higher levels of the redox sensitive transcription factor 
NFκB (p65) were observed in proximal tubular nuclear extracts of obese rats 
compared to lean rats (fig. 25). Exercise significantly decreased the nuclear 
content of NFκB (fig. 25). The decrease in nuclear content of NFκB was 
accompanied with a corresponding increase in the cytosolic content indicating 
that exercise reduced the nuclear translocation of NFκB in obese rats (fig. 25). 
4.3 EFFECT OF CALORIC RESTRICTION: 
The results described below are from studies conducted in homozygous Zucker 
Leprfa/fa (obese Zucker) rats that were either provided ad-libitum access to food 
Page 62 of 152 
or were calorie restricted. Calorie restricted group was provided 50% of the food 
consumed by ad-libitum from seven weeks of age for ten weeks (seventeen 
weeks of age). 
4.3.1 Effect of caloric restriction on general physiological parameters: Ad-
libitum group consumed approximately 40-45 grams of food from 7 weeks of age 
until seventeen weeks of age (fig. 26A). Caloric restriction group was provided 
half the amount of food consumed by ad-libitum group (fig. 26A). Water intake in 
caloric restriction group was significantly lesser when compared to ad-libitum 
throughout the period of study (fig. 26B). Caloric restriction resulted in a 
significant decrease in weight gain when compared to ad-libitum group starting 
from the first week and lasted throughout the period of study (fig. 26C). Mean 
arterial pressure was similar in both the groups (fig. 27A). Fasting blood glucose 
levels were similar in both the groups (fig. 27B). However, caloric restriction 
resulted in ~50% decrease in fasting plasma insulin levels (fig. 27C) and 
improvement of insulin sensitivity (QUICKI) (fig. 27D). 
Caloric restriction reduced triglyceride levels by ~40% (Table 4). Total cholesterol 
levels were similar in both the groups (Table 4). However, we could not 
statistically evaluate HDL cholesterol levels because the levels were above the 
detection limit in all except one of ad-libitum and five of caloric restriction group 
(Table 4). Caloric restriction significantly decreased body weight and the ratios of 
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fat, heart and spleen to body weight, compared to ad-libitum group (Table 4). 
However, ratio of kidney and liver to body weight were similar in both the groups 
(Table 4). 
4.3.2 Effect of caloric restriction on oxidative stress: 
4.3.2.1 Plasma and urinary 8-isoprostane: 
Caloric restriction decreased plasma 8-isoprostane by ~20% (fig. 28A). In 
contrast, urinary 8-isoprostane levels were approximately three fold higher in 
caloric restriction group (fig. 28B). 
4.3.2.2 Renal cortical protein carbonylation: 
Caloric restriction did not alter the levels of protein carbonylation when compared 
with ad-libitum group (fig. 29). Since no bands were detected for derivatization 
controls in both the groups (fig. 29, upper panel, lanes 2 and 4), the entire strip of 
protein bands was used for quantification. 
4.3.2.3 Renal cortical nitrosylation: 
Caloric restriction did not reduce protein nitrotyrosine content in renal cortices 
when compared with ad-libitum group (fig. 30). 
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4.3.2.4 Plasma and renal cortical superoxide dismutase: 
Caloric restriction did not affect the levels of superoxide dismutase in both the 
plasma (fig. 31A) and renal cortical homogenates (fig. 31B). 
4.3.2.5 Renal cortical malondialdehyde: 
Caloric restriction did not reduce renal cortical malondialdehyde levels when 
compared to ad-libitum group (fig. 32). 
4.3.3 Effect of caloric restriction on natriuretic response to SKF38393: 
Both caloric restriction and ad-libitum group displayed similar basal diuresis (fig. 
33) and urinary sodium excretion (fig. 34). While SKF38393 significantly 
increased diuresis in both groups (fig. 33) it failed to increase urinary sodium 
excretion in both the groups (fig. 34). 
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5. DISCUSSION: 
Our results show that, in obese Zucker rats, the exercise protocol employed in 
this study reduces oxidative stress by augmenting antioxidant defenses and also 
reduces albuminuria. However, it fails to lower blood glucose levels or improve 
insulin sensitivity, does not restore renal dopamine D1 receptor coupling to G 
proteins or renal dopamine D1 receptor mediated natriuresis and does not 
prevent the development of hypertension. This is despite the observation that the 
reduction in oxidative stress levels was enough to prevent the nuclear 
translocation of redox sensitive transcription factor NFκB that has been 
implicated in the impairment of natriuretic response to D1 receptor agonists in 
several models of hypertension, diabetes and aging (27, 30, 63, 64). This study 
provides evidence that reducing oxidative stress per se is not enough to restore 
renal D1 receptor function in this model. In addition to lowering oxidative stress, 
reducing insulin and/or blood glucose levels may play an important role in 
restoring renal D1 receptor function. Further, this study provides additional 
evidence that restoring D1 receptor function contributes to reducing blood 
pressure in obesity-associated hypertension. 
The exercise protocol employed in our study did not reduce food intake or the 
gain in weight in obese rats. While some studies have reported moderate 
reductions in weight gain in female obese rats with swim training (217, 218), 
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several other groups have reported results that are similar to our study (133, 149, 
194). Nevertheless, even in studies that reported reductions in weight gain, 
exercise only delayed but did not prevent the development of obesity (217). 
Inability of exercise to reduce weight gain, in this model, might be related to lack 
of attenuation of leptin resistance and the associated hyperphagia and impaired 
thermogenesis (16, 172). In a clinical trial involving children 8-14 years of age, 
Reinehr et al (186) have reported that plasma leptin concentrations are a 
predictor of overweight reduction with a lifestyle intervention. Although we did not 
measure leptin levels, others (117, 172, 221) have reported that exercise does 
not reduce leptin levels in these rats. 
Exercise did not reduce blood pressure, fasting blood glucose or plasma insulin 
levels in obese rats. Exercise in both normal and overweight subjects has 
generally been associated with moderate decreases in blood pressure (220), 
improved insulin sensitivity and moderate reductions in blood glucose levels 
(166, 197). However, a meta-analysis study of exercise in type II diabetic patients 
showed that exercise failed to decrease blood pressure in this patient subset 
(206). In addition, even studies that report reductions in blood pressure, the size 
of this effect decreases with increasing body-mass-index (BMI) (220). A longer 
duration of exercise (14-22 weeks) has been shown to reduce systolic blood 
pressure in these rats using tail cuff method (17, 180). It is possible that the 
shorter duration of exercise (8 weeks) in our study precluded us from observing a 
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decrease in blood pressure. However, stress due to the restraining procedure 
involved in tail cuff method can limit the interpretation of data by providing false 
high values of blood pressure (213). Since exercised rats are more accustomed 
to handling and restraining in a narrow space compared to sedentary rats, it is 
possible that they displayed lesser stress during measurement of blood pressure. 
This might have been responsible for the apparent lower blood pressures in both 
the lean and obese exercised groups. Our results are similar to other studies in 
this model that did not notice any improvements in blood pressure with exercise 
(81, 221). Xiang et al (221) have reported a decrease in insulin levels with 
exercise. However, a number of other studies have reported no reductions in 
fasting plasma insulin levels with exercise in obese rats (38, 48, 53, 55, 117, 126, 
169, 171, 203) as well as humans (206). While some studies have reported that 
insulin resistance in this model is refractory to exercise (149) others have 
reported improvements (133, 218). Further, even in studies reporting an 
improvement in insulin sensitivity, there were no reductions in fasting plasma 
insulin concentrations (53, 133, 169, 218). While our study involved 8 weeks of 
exercise at 10m/min, Xiang et al (221) exercised the rats for 4-5 weeks at 
24m/min. However, the difference in intensity of exercise may not be responsible 
for the difference in the effect on insulin levels. Our results are in agreement with 
other authors who, using intensities ranging 20-26 m/min for more than 5 weeks, 
have reported no reductions in insulin levels with exercise (38, 53, 55, 117, 171). 
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Obese rats display higher HDL cholesterol levels and exercise paradoxically 
decreased HDL cholesterol levels in these rats. Higher HDL levels have normally 
been associated with lower LDL oxidation and better anti-inflammatory and anti-
atherogenic profile (86). However, recent research suggests that HDL levels per 
se might not correlate with these beneficial effects (5, 44). Conditions like 
hyperglycemia, oxidative stress and chronic acute phase response seen in 
obesity and diabetes (both type I and II), can alter HDL composition and structure 
and actually promote LDL oxidation and inflammation (104, 161-164, 175-177, 
212). In addition, our results are similar to those of Roberts et al (187), who 
reported that aerobic exercise in humans exhibiting metabolic syndrome actually 
decreases HDL levels while improving its anti-inflammatory properties. While 
exercise significantly reduced triglyceride levels in obese rats, it failed to 
decrease blood cholesterol levels in our study. A similar lack of effect of exercise 
on blood cholesterol levels has been reported in type II diabetic patients (206) 
and obese rats (117). Boor et al (38) did not observe any effect on triglyceride 
levels with 10 weeks of exercise in obese Zucker rats. The reason for differences 
between our study and the above study are not clear. However, we suspect that 
this might be due to the overnight fasting protocol employed in our study. Boor et 
al (38) do not mention if the rats were fasted overnight and the triglyceride levels 
in their study might reflect postprandial/random levels. In addition, our results are 
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similar to those of Frisbee et al (81) who, using 10 weeks of exercise and an 
overnight fasting period, observed a similar decrease in triglyceride levels. 
Previously we have reported that anti-oxidant treatment of Fisher344 rats (64), 
obese rats (32, 144) and pro-oxidant treated SD rats (30) reduced oxidative 
stress and restored dopamine D1 receptor function. Further, exercise has been 
reported to augment physiological antioxidant mechanisms and improve renal 
dopamine D1 receptor function in old Fisher344 rats (19, 84). A critical role of 
NFκB nuclear translocation in impairment of dopamine D1 receptor function and 
its restoration following anti-oxidant treatment has been demonstrated in primary 
cultures (63) and pro-oxidant treated SD rats (30). In the present study, exercise 
reduced oxidative stress in obese rats as evidenced by increase in SOD activity 
in both plasma and proximal tubular homogenates and reductions in levels of the 
oxidative stress markers, urinary 8-isoprostane and renal malondialdehyde. 
These reductions in oxidative stress were enough to prevent the nuclear 
translocation of redox sensitive transcription factor NFκB that has been 
implicated in the development of renal dopamine D1 receptor dysfunction. 
However, we did not observe an improvement in dopamine D1 receptor mediated 
[35S]GTPγS binding and sodium excretion, or reduction of blood pressure in this 
study. 
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The above results and also studies in other models suggest that oxidative stress 
might not be responsible for impairment of dopamine D1 receptor function and 
development of hypertension in all cases. For example, Escano et al (62) have 
shown that C57Bl/6J mice exhibit higher blood pressure compared to SJL/J mice, 
exhibit dopamine D1 receptor dysfunction and develop salt sensitive 
hypertension while SJL/J mice do not. However, when on high salt diet, SJL/J 
mice exhibit higher levels of oxidative stress compared to C57Bl/6J mice 
suggesting that oxidative stress is not always responsible for impairment of renal 
dopamine D1 receptor function and development of hypertension (62). In the light 
of these findings, it is possible that oxidative stress is not critical in the 
development of dopamine D1 receptor dysfunction and hypertension in obese 
Zucker rats. 
Exercise reduced urinary albumin excretion in our study. In contrast, Boor et al 
(38) reported an increase in urinary protein levels with exercise. In this particular 
study the rats were placed in metabolic cages right after the last exercise session 
to collect urine used for measuring protein. Boor et al (38) acknowledge that this 
is a drawback of their study design, since it does not eliminate the acute effects 
of exercise. In addition, the authors report a decrease in number of glomeruli 
exhibiting protein droplets in their histopathological studies and this might 
actually indicate an improvement in terms of reducing proteinuria. In our study, 
we collected urine from the bladder 48hrs after the last bout of exercise to 
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eliminate the acute effect of exercise on proteinuria. Further, as pointed out by 
Boor et al, a number of other studies support our observation that exercise 
reduces proteinuria (19, 51, 219). 
In our study, exercise reduced proximal tubular oxidative stress, reduced 
albuminuria and decreased proximal tubular NFκB activation in obese rats. While 
albuminuria is used as a marker of renal (glomerular) injury, it is reported that 
albuminuria can by itself initiate a vicious cycle of proximal tubular injury and 
oxidative stress (116). Morigi et al (152) have shown that albumin induces 
proximal tubular injury via a mechanism involving generation of reactive oxygen 
species (ROS) and activation of NFκB. Also, increased oxidative stress in SJL/J 
mice makes them susceptible to increased albuminuria and renal injury when 
compared to C57Bl/6J mice (62). In addition, Quigley et al (182) have reported 
that renal injury in obese (db/db) mice might result from increased oxidative 
stress rather than increased blood pressure. Our findings are similar to the above 
reports in that a reduction in oxidative stress with exercise was associated with 
decrease in albuminuria but not blood pressure. 
Therefore, this study offers evidence that exercise is beneficial in reducing 
oxidative stress, nuclear translocation of NFκB and renal injury in obese Zucker 
rats. However, the reductions in oxidative stress are not enough to prevent renal 
dopamine D1 receptor dysfunction and development of hypertension. In addition, 
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considering previous studies (25, 26, 29), we predicted that reducing insulin 
levels may be an important pre-requisite to prevent renal dopamine D1 receptor 
dysfunction that contributes to development of hypertension in this model. 
Another piece of evidence indicating the primary role of insulin was our study in 
Leprfa/fa (obese) Zucker rats, at three to four weeks of age. At this age, the 
Leprfa/fa (obese) Zucker rats are hyperinsulinemic and dyslipidemic but do not 
display hyperglycemia or significantly elevated blood pressure. At this age, 
proximal tubular SOD activity is decreased when compared to Lepr-/- (lean) 
Zucker rats. However, other antioxidant components like reduced-glutathione 
(GSH) and hemeoxygenase-1 (HO-1) were not decreased when compared to 
lean rats. In addition, several markers of oxidative stress like plasma and urinary 
8-isoprostane, proximal tubular protein carbonylation, proximal tubular protein 
nitrosylation, and the ratio of reduced-glutathione to oxidized-glutathione were 
similar when compared with lean rats. In addition, the nuclear translocation of 
redox sensitive transcription factor NFκB was similar in both the groups. 
Therefore, Leprfa/fa (obese) Zucker rats, at three to four weeks of age, do not 
display oxidative stress or increased nuclear translocation of NFκB. Furthermore, 
three-week-old obese Zucker rats do not display downregulation of dopamine D1 
receptor compared to age matched lean controls. Despite this, dopamine D1 
receptor mediated inhibition of Na+/K+ ATPase at this age is impaired when 
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compared to lean rats. Defective dopamine D1 receptor-G protein coupling, 
evidenced by inability of dopamine D1 agonist (SKF38393) to stimulate 
[35S]GTPγS binding, might be responsible. Considering these results in three-
week-old obese Zucker rats, the results from our exercise study, and earlier 
studies using antioxidants (21, 32), we concluded that reducing hyperinsulinemia 
might be a prerequisite to restore dopamine D1 receptor function. 
Another lifestyle intervention that is recommended for reducing weight gain and 
lowering blood pressure is restriction of caloric intake (155, 160). In addition, 
adequate amount of caloric restriction (~50% restriction) in obese Zucker rats, 
starting at an early age, is associated with decrease in insulin levels (22, 141). 
Therefore, we hypothesized that caloric restriction in obese Zucker rats from an 
early age will reduce insulin levels, restore renal dopamine D1 receptor function 
and reduce blood pressure. 
Caloric restriction in obese Zucker rats, starting from seven weeks of age, 
decreased the gain in weight in these rats when compared with ad-libitum group. 
This reduction in the rate of weight gain was associated with a reduction in 
triglyceride levels and a marginal decrease in ratio of fat to body weight. In 
addition, caloric restriction decreased fasting insulin levels and improved insulin 
sensitivity. However, these changes were not associated with restoration of 
natriuresis in response to dopamine D1 receptor agonist (SKF38393) or a 
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decrease in blood pressure. Caloric restriction reduced insulin levels by ~50% 
when compared with ad libitum group. Our observations regarding insulin levels 
are similar to studies from other labs (22, 141) and offer further evidence that 
caloric restriction to lean levels, starting at an early age, reduces insulin levels 
and improves insulin sensitivity. However, our observations regarding blood 
pressure are in contrast to those of Maddox et al (141) who observed a reduction 
in blood pressure in conscious rats using the tail cuff method. We measured 
blood pressure via a carotid artery catheter in anesthetized rats. Our results are 
similar to those of Kurtz et al (131) who also measured arterial pressure directly 
via femoral catheters in conscious rats, thus ruling out the possibility of 
interference from anesthesia. Another explanation for the differences between 
our study and that of Maddox et al (141) might be the drawbacks presented by 
the tail cuff method (213). The reductions in blood pressure reported by Maddox 
et al (141) might potentially reflect the variable reactivity of blood pressure to 
stress rather than treatment (caloric restriction) effect (213). 
While caloric restriction reduced fasting insulin levels and improved insulin 
sensitivity it failed to reduce oxidative stress. Caloric restriction failed to increase 
SOD activity in both the plasma and renal cortical homogenates. Caloric 
restriction failed to decrease protein carbonylation, protein nitrosylation, and 
malondialdehyde levels in renal cortical homogenates, when compared with ad-
libitum group. Although caloric restriction marginally decreased (by ~20%) 
Page 115 of 152 
plasma 8-isoprostane levels, it increased urinary 8-isoprostane levels 
approximately three fold. These results might indicate a difference in the effect of 
caloric restriction on systemic oxidative stress versus local effect in the kidney. In 
fact, caloric restriction might actually increase renal oxidative stress as is 
evidenced by increased urinary 8-isoprostane levels. An alternative explanation 
for the increase in urinary 8-isoprostane levels might be the fact that caloric 
restriction has been reported to decrease the protein levels of cyclo-oxygenase 1 
and 2 (COX 1/2) (183). This decrease in COX 1/2 might increase the arachidonic 
acid pool available for oxidative conversion to 8-isoprostane. Irrespective of the 
source of the increased urinary 8-isoprostane levels, this increase might have 
important physiological and possibly pathophysiological implications. 
Isoprostanes are potent vasoconstrictors that can decrease renal blood flow and 
glomerular filtration rate (GFR) (23, 153, 154). This vasoconstrictor effect, at low 
nanomolar concentration, seems to be renal specific and not systemic because 
an acute infusion that achieves this concentration does not elevate blood 
pressure (153). The effect of isoprostanes on electrolyte reabsorption, 
specifically dopamine-mediated inhibition of sodium reabsorption, is still 
unexplored. Regardless, these results indicate that caloric restriction failed to 
decrease oxidative stress and did not restore dopamine D1 receptor mediated 
natriuresis in obese Zucker rats. 
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Therefore, caloric restriction in obese Zucker rats decreases insulin levels and 
improves insulin sensitivity. However, caloric restriction does not reduce 
oxidative stress, does not restore renal dopamine D1 receptor function, and does 
not reduce blood pressure in these rats. 
LIMITATIONS: 
The above discussion needs to be qualified by the complexity presented by the 
obese Zucker rat as a model of metabolic syndrome. Although our study and 
previous studies indicate a critical role of hyperinsulinemia and oxidative stress in 
the impairment of renal dopamine D1 receptor function in this model, it is 
possible that other factors play an important role. In addition, it is possible that 
restoration of renal dopamine D1 receptor function by tempol is related to the 
correction of condition(s) other than hyperinsulinemia and oxidative stress. It 
follows that both exercise and caloric restriction might have failed to restore renal 
dopamine D1 receptor function as a result of the inability to correct the above 
condition(s) that conceivably was/were corrected by tempol. 
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6. SUMMARY AND CONCLUSIONS: 
6.1 SUMMARY: 
In obese Zucker rats 
1. Hyperinsulinemia, dyslipidemia and impairment of renal dopamine D1 
receptor function precede the development of hyperglycemia, oxidative 
stress and the associated increase in nuclear translocation of NFκB, and 
hypertension. 
2. Exercise is beneficial in improving lipid profile, reducing oxidative stress, 
reducing nuclear translocation of NFκB and reducing renal injury. 
However, exercise does not reduce rate of weight gain, does not decrease 
insulin levels or improve insulin sensitivity, does not correct renal 
dopamine D1 receptor dysfunction and does not reduce blood pressure. 
3. Caloric restriction improves lipid profile, reduces the rate of weight gain, 
reduces insulin levels and improves insulin sensitivity. However, caloric 
restriction does not decrease oxidative stress, does not correct renal 
dopamine D1 receptor dysfunction and does not reduce blood pressure. 
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6.2 CONCLUSION: 
Considering the above studies and previous literature, we conclude that both 
hyperinsulinemia and oxidative stress can independently impair renal dopamine 
D1 receptor function contributing to the development of hypertension in obese 
Zucker rats. As a corollary, simultaneously reducing both oxidative stress and 
hyperinsulinemia might be required to restore renal dopamine D1 receptor 
function and attenuate hypertension. Either exercise or caloric restriction, 
independently, fails to simultaneously correct both hyperinsulinemia and 
oxidative stress in these rats. Therefore, renal dopamine D1 receptor impairment 
and development of hypertension cannot be corrected/attenuated by either 
intervention in isolation. A combination of both exercise and caloric restriction 
may be required to restore renal dopamine D1 receptor function and lower blood 
pressure in obese Zucker rats. 
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